Analysis of protein expression in the autonomic ganglia of horses with respect to equine grass sickness by Peaston, Emily
 
 
 
 
 
 
 
https://theses.gla.ac.uk/ 
 
 
 
 
Theses Digitisation: 
https://www.gla.ac.uk/myglasgow/research/enlighten/theses/digitisation/ 
This is a digitised version of the original print thesis. 
 
 
 
 
 
 
 
 
Copyright and moral rights for this work are retained by the author 
 
A copy can be downloaded for personal non-commercial research or study, 
without prior permission or charge 
 
This work cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the author 
 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the author 
 
When referring to this work, full bibliographic details including the author, 
title, awarding institution and date of the thesis must be given 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten: Theses 
https://theses.gla.ac.uk/ 
research-enlighten@glasgow.ac.uk 
UNIVERSITY
ofGLASGOW
Analysis o f Protein Expression in the Autonomic 
Ganglia o f Horses with Respect to Equine Grass 
Sickness
Emily Peaston BSc (Hons)
Division of Infection and Immunity 
The Joseph Black Building 
The University of Glasgow 
Glasgow 
G12 8QQ
Dept Veterinary Clinical Studies 
University o f Edinburgh 
Easter Bush Veterinary Centre 
Easter Bush, Roslin 
Midlothian, EH25 9RG
A thesis presented for the degree o f  Master o f Science by Research 
in the Faculty o f  Biomedical and Life Sciences, 
University o f  Glasgow.
The Royal (D ick) School o f  Velerinan' Studies
ProQuest Number: 10395742
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 10395742
Published by ProQuest LLC (2017). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkway 
P C. Box 1346 
Ann Arbor, Ml 48106- 1346
s #
I declare that all work within this thesis is my own, unless specifically indicated.
Emily Peaston
Date
II
Summary
Equine grass sickness (EGS) is essentially a fatal disease of the horse with clinical 
symptoms that indicate autonomic nervous system (ANS) dysfunction. Such symptoms 
include vaiying degrees of colic, intestinal stasis, dysphagia, anorexia, weight loss, 
tachycardia, excessive salivation, patchy sweating, ptosis (drooping of the eye lids), 
rhinitis sicca and muscle tremor (Hudson et al, 2001), Furthermore, a characteristic loss 
of stainability (cliromatolysis) is commonly seen in neurones of the gut wall plexi, 
prevertebral and paravertebral ganglia, the intermediolateral tract of the spinal cord and 
certain brain stem nuclei in EGS cases.
The disease is recognised in three loosely defined clinical categories: acute (disease 
duration 1-2 days), sub-acute (2-7 days) and chronic (>7 days). It is hypothesised that a 
neurotoxin is ingested and the extent of the nervous damage is dose dependent. It is also 
considered that massive neuronal loss likely results in the acute form, whilst less neuronal 
damage results in less severe signs and the chronic form of the disease (Cottrell et al, 
1999). The aetiology of EGS is largely unknown. However, the working hypothesis is 
that it is a toxicoinfection with Clostridium botulinum type C, possibly triggered by 
dietary factors such as cyanide from white clover {Trifolium repens).
In this study protein expression in homogenates of cranial cervical ganglia collected from 
horses with acute EGS (AGS) and from control horses was analysed using two- 
dimensional electrophoresis (2D-E). Optimal sample preparation and 2D-E teclmiques 
were developed for the first time for equine neural tissue. Variations in the protein 
expression between samples from different locations within the same autonomic ganglia, 
different autonomic ganglia from the same horse, ganglia from different horses of the 
same sex and ganglia from horses of both sexes were investigated using the 2D-E method 
developed. It was concluded that the variations in protein expression between such 
samples would not affect further comparisons between AGS and control 2D-E tissues and 
would not interfere with identifying EGS-related proteins. At this point a 2D-E gel was 
mn with sample from control equine autonomic ganglia and sixty spots were subjected to 
MALDI-MS analysis to construct a preliminary proteome map of equine autonomic 
ganglia. This will provide a useful reference for future research.
The protein expression on 2D-E gels of AGS and control samples was analysed and any 
differences were highlighted. Fourteen spots were identified as being up-regulated or 
only occurring on AGS sample gels and were considered to be AGS related. These 
proteins were analysed using Matrix-Assisted Laser Desorption Ionisation Mass 
Spectrometry (MALDI MS) and tandem MS. After MS analysis the majority of these 
proteins were recognised as neural proteins (e.g. beta tubulin and gamma enolase) or 
semm proteins. The presence or up-regulation of some of the proteins in AGS, such as 
alpha-l-antitiypsin, chaperonin/HSP60, beta tubulin and gamma enolase may well, with 
further investigation, help reveal the aetiology of EGS by clarifying the nature of the 
damage that occurs during EGS.
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Chapter One: Background
1.1 Equine grass sickness
1.1.1 Inti'oduction
Equine grass sickness (EGS) is a dysautonomia of unknown aetiology that affects 
horses. The disease is characterised by the paralysis, and hence dysfunction of the 
alimentary tract and in the majority of cases is fatal. Other symptoms include vaiying 
degrees of colic, intestinal stasis, dysphagia, anorexia, weight loss, tachycardia, 
excessive salivation, patchy sweating, ptosis (drooping of the eye lids), rhinitis sicca 
and muscle tremor (Hudson et al, 2001). Furthermore, a characteristic loss of Nissl 
substance (chromatolysis) is commonly seen in neurones of the gut wall plexi, 
prevertebral and paravertebral ganglia, the intermediolateral tract of the spinal cord and 
certain brain stem nuclei in EGS cases (Hudson et al, 2002).
EGS was first recognised in Scotland around 1 0 0  years ago (Tocher, 1924). However, it 
is now known to be present throughout the UK and much of Northern Europe with 
isolated cases also being reported in South America and the Falkland Islands (Cottrell et 
al, 1999; Hahn et al, 2001). Nevertheless, its highest incidence remains in Scotland and 
North East England, killing around one in two hundred horses every year (Milne and 
McGomm, 2000). Epidemiological studies have shown a high incidence during the 
spring, when horses are turned out to grass. Similar studies also indicate the latency of 
the disease to be about two weeks (Doxey et a,. 1992). Young, usually 2-7 years old, 
stressed horses and horses that have recently been moved to new pastures appear to be 
most at risk. However, cases consistently occur in all breeds and types of horses (Doxey 
et al, \992).
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Table 1.1. The clinical presentation of equine grass sickness (from Dr Scott Pirie - 
Royal (Dick) School of Veterinary Studies, University of Edinburgh, Equine Grass 
Sickness Fund Website, www.grasssickness.org.uk). Summary of the clinical signs of 
grass sickness, associated with the three forms of the disease.
ACUTE SUBACUTE ! CHRONIC
• Depression/ • "Tucked up" \ • Severe weight loss |
somnolence abdomen j • Markedly "tucked up" \
• Distended • Weight loss | abdomen \
abdomen • Dysphagia | • Base narrow stance
• Ileus (absence of j (difficulty 1 • Rhinitis sicca (inflamed |
gut sounds) swallowing) | nasal passages) j
• Tachycardia • Tachycardia | • Ptosis (drooping eyelids) \
(high heart rate) • Colic (as disease j • Slightly elevated heart rate!
• Salivation progresses) | (< 60 bpm usually)
• Gastric reflux • Gastric reflux (as • Muscle tremors
• Muscle tremors disease progresses) | • Patchy sweating :
•  Ptosis (drooping •  Patchy sweating | • Mild colic j
eyelids) •  Ptosis (drooping | •  Reduced gut motility j
•  Patchy/generalis eyelids) |
ed sweating • Muscle tremors
• Dysphagia • Colon impaction
(difficulty • Reduced gut
swallowing) motility
• Small intestinal
distension
• Colic
(occasionally)
• Colon
impactions
(occasionally)
EGS can present in one of three forms: acute, subacute and chronic, each varying in the 
rapidity of outcome and the severity and duration of the symptoms (table 1.1). In acute 
EGS, the most severe and invariably fatal foim, the symptoms can arise very rapidly 
and the duration of the disease is typically 24-48 h, ending with the death of the animal 
- usually due to euthanasia on humane grounds. Subacute EGS is not quite as severe or
as rapid in onset, but is also invariably fatal, and typically lasts for 2-7 days. Chronic 
EGS, in contrast, can take weeks to develop and may persist for months (Doxey et al, 
1991b; Hudson et al, 2002). At present, approximately 30% of chronic cases can be 
nursed through the symptoms, with little residual damage and a normal, even full 
competitive life resuming on recovery (Milne and McGorum, 2000). The cause of EGS 
is not known, but it is currently thought that the horse may ingest a neurotoxin 
(Griffiths et al, 1994a) and that the degree of nervous damage is dose related, thereby 
determining the severity of the disease (Barlow, 1969; Pogson et al 1992; Doxéy et al, 
1992,1995a).
1.1.2 EGS and Clostridium botulinum
Currently, the working hypothesis is that EGS is a toxicoinfection with Clostridium 
botulinum type C (Hunter et al, 1999; Hunter and Poxton, 2001). The botulinum 
neurotoxins are a family of protein toxins that selectively inhibit the release of 
acetylcholine (ACh) at the neuromuscular junction and autonomic ganglia (Habermann 
and Dreyer, 1986; Simpson, 1989; Niessmann et al, 1994). Seven immunologically 
distinct serotypes of botulinum toxin have been identified and designated A-G by the 
order of their discovery (Habermann and Dreyer, 1986; Simpson, 1989). The dichain 
protein toxins are produced by the anaerobic bacterium Clostridium botidinum. A 
strong correlation between EGS and the detection of Clostridium botulinum type C 
neurotoxin (Cl toxin) in the ileum and faeces of horses with EGS has been made 
(Hunter cr <3 /, 1999).
Professor Ian Poxton of the University of Edinburgh is currently researching the link 
between Clostridium botulinum and EGS (Poxton, http://www.grasssickness.org.uk).
He has proposed that, under noiinal circumstances, most horses at some point have 
been exposed to the bacterium, but the gut flora can resist the growth of the organism 
and the production of its toxins. However, an as yet unidentified sudden change or 
dismption of the nonnal gut flora (e.g. a change in nutrition/change of pasture) may 
allow for an abnomially increased production of toxins in the gut. This, in turn, could 
cause the dysfunction of the autonomic nervous system that characterises EGS.
1.1.3 EGS and oxidative stress
There are two ongoing studies to identify the putative trigger for the overgi'owth of 
Clostridium botulinum. The first study investigated a possible linlc between oxidative 
stress and excitotoxicity with EGS (McGorum et al, 1998). It is hypothesised that 
plants and grasses which undergo metabolic stress during periods of rapid gi'owth or 
extreme weather conditions may contain limited amounts of antioxidants and elevated 
levels of excitotoxic amino acids, e.g. glutamate and aspartate (Bortosz, 1997; 
Haraguchi, 1997). higestion of these metabolites could potentially contribute to EGS 
(McGomm et al, 2000). The second study is investigating the role of cyanide from wild 
white clover {Trifolium repens) as a trigger factor. Pasture improvement schemes using 
white clover have been related to EGS. The first reports of EGS, in the early 1900s, 
coincided with the introduction of wild white clover into the grass seed mixtures used 
to improve agricultural productivity in Scotland (McGorum, 2001). The cyanogenic 
glycosides in white clover, which have the capability to release cyanide, a known
neurotoxin, could cause the overgrowth of Clostridium botulinum. Certain observations 
support this hypothesis:
The cyanide content in white clover increases when the plant is rapidly growing, for 
example during the springtime, which, as previously mentioned, is a peak time for 
EGS cases (Doxey, 1991).
The content of cyanide has also been shown to increase following the exposure of the 
plant to adverse weather conditions, such as drought, frost and snow. EGS has 
repeatedly been shown to occur following long periods of cold dry weather and 
overnight frosts (Doxey, 1991).
Current research, by Prof Bruce McGomm, at the Royal (Dick) School of Veterinary 
Studies, Edinburgh, has shown that white clover collected from fields following a 
recent outbreak of EGS frequently has elevated levels of cyanogenic glycoside 
(McGorum, personal communication). Furthermore, it was shown that the blood and 
urine obtained from exposed horses grazing EGS pastures indicated that these horses 
had been subjected to increased cyanide exposure. Horses with EGS also showed 
alterations in blood amino acids resembling those found in humans with chronic 
cyanide poisoning (McGomm, 2001).
1,1.4 Putative neurotoxins
By the fractionation of plasma, taken from blood from horses with AGS, and using gel 
filtration and salt precipitation, a >30kDa neurotoxin has been found in the semm of GS
affected horses (Gilmour and Mould, 1977). The preparations were tested for 
neurotoxic activity by injection into ponies. The resulting neurohistological changes, 
like those seen in EGS, suggested its association with grass sickness. The neurotoxin 
was confirmed to be of high molecular weight range and a proteinacious molecule or 
bound to a high molecular weight protein (Gilmour and Mould, 1977). This protein has 
also been reported to be capable of inducing autonomic neuropathy, but not the clinical 
signs of EGS, when administered either intraperitoneally (Gilmour, 1973; Gilmour and 
Mould, 1977), or directly into the parotid salivary gland (Griffiths et al, 1994a). It is 
believed that the putative neurotoxin affected the neurones by retrograde axonal 
transport (Griffiths et al, 1994a).
However, little else is known about this proteinacious neurotoxin, and it has not yet 
been characterised, despite previous attempts (Pemberton et al, 1990). It is possible that 
the protein could represent C botulinum toxin, or a botulinum toxin associated with a 
protein carrier such as albumin (Griffiths et al, 1994b). Alternatively, the protein may 
be a neurotoxin unrelated to C. botulinum toxin, a metabolite produced as a result of 
oxidative stress or cyanide poisoning, for example.
1.2 Proteomics
1.2.1 Introduction
Proteins are the main catalysts of biological function and contain many levels of 
information that collectively indicate the actual rather than the potential functional 
state. Protein quantity, location and time-point can all be measured to detennine this
flinctional state (Yanagida, 2002). Proteomics is the systematic analysis of protein 
expression patterns in cells and tissues. It involves the isolation, separation, 
identification and functional characterisation of the proteins in an organism. Two- 
dimensional gel electrophoresis (2D-E) offers the greatest protein resolution potential 
compared to any other currently available separation method. It is also useful for the 
identification of changes in protein expression (Cohen et al, 2002), which would be 
especially helpful in the investigation of diseased tissues. The term “proteome” was 
suggested in the mid 1990s as a collective tenu for the total protein complement of a 
cell or a tissue. Hence, proteomics has developed as the study of proteomes (Wasinger 
et al, 1995; Wilkens et al, 1996).
1.2.2 Two-dimensioual electrophoresis
Using two-dimensional (2-D) gel electrophoresis (a combination of isoelectric focusing 
[lEF] and sodium dodecyl sulfate polyacrylamide gel electrophoresis [SDS-PAGE]) 
proteomes can be analysed with high resolution. Both their molecular weight and 
isoelectric points can separate thousands of proteins that are expressed in a specific cell 
or a tissue. This high resolution can help determine which proteins are present in a cell 
or tissue under specific states (Yanagida, 2002). It is, therefore, possible to identify and 
isolate differentially expressed proteins in response to changes in the cell or tissue by 
comparison of various states of the sample. For example, the differential protein 
expression between diseased and non-diseased cells or tissues can be established.
As an example of the value of proteomic analysis, the differential protein expression 
between Alzheimer’s diseased (AD) brain tissue and control brain tissue was analysed 
by the use of 2D-E (Tsuji et al, 1999). In this study, the brain samples were taken from 
the temporal cortex of brains at autopsy. Fifteen AD patients and fifteen age-matched 
(control) patients were studied. Following extraction and solubilisation of proteins from 
the samples, the proteins were separated using 2D-E along with marker proteins to 
enable the estimation of the molecular weights and isoelectric points of the unlaiown 
proteins. The gels were stained and scanned to digitise them such that comparisons of 
protein appearance on the gels, and up/down regulation of spots could be perfonned. A 
number of interesting observations were made. Five protein spots were identified as 
being significantly increased (two of which were characterised as glial fibrillary acidic 
protein) in AD patients and nine spots were found to be present in AD brains only. No 
proteins were present in controls that were not present in AD brains, but 28 spots (one 
was identified as glial fibrillary acidic protein) were identified as down regulated.
Such observations were made possible by the high-resolution separation of proteins 
achieved using 2D-E. The reproducibility of the gels was improved by the use of 
immobilised pH gradient (IPG) first dimensional strips (Tsuji et al, 1999). Furthermore, 
the database of brain proteins in AD constmcted in this study, along with the statistical 
data of density changes of proteins in AD, provided an invaluable beginning for a 
comprehensive human brain 2D-E database, facilitating further investigation of 
pathogenic protein alterations in AD. However, Tsuji et al (1999) did still encounter 
limitations with regards to the separation of proteins. They were unable to demonstrate
proteins of molecular weight exceeding lOOlcDa. This could have been due to the 
limited ability of heavy proteins to enter the first dimension IPG gel strip. Furthermore, 
it is widely accepted that hydrophobic proteins (such as membrane proteins) can be 
difficult to resolve using 2D-E teclmiques, due to the charge of the proteins interfering 
with the lEF separation stage.
1.2.3 Mass Spectrometry and proteomics
The introduction of mass spectromic (MS) teclmiques greatly improved protein 
identification strategies. The development of time-of-flight (ToF) mass spectrometers 
and soft ionisation methods, including matrix-assisted laser desorption ionisation 
(MALDI) and electrospray ionisation (ESI), has facilitated the accurate measurement of 
the molecular mass of biomolecules (Yanagida, 2002). Proteins usually separated by 
gel electrophoresis are first digested with a sequence-specific endopeptidase such as 
trypsin, subsequently ionised, and analysed by MS. A mass spectrometer determines 
the molecular weight of chemical compounds by ionising, separating, and measuring 
molecular ions according to their mass-to-charge ratio (jn/z) (Scripps Centre for mass 
spectrometry, www.masspec.scripps.edu/information/intro/index.html). In MALDI- 
ToF-MS, a sample (e.g. protein sample) is mixed with a matrix in the presence of a fast 
evaporating solvent, under extremes of pH, usually achieved by adding triflouroacetic 
acid (TFA) (Guptasaiina, 2001). After mixing, the entire solution is placed on a stage 
(or platform) and the solvent is allowed to evaporate. This causes the matrix to 
crystallise, with the sample being non-specifically associated with the crystallising 
compound. The crystallised mixture is then placed in a vacuum, and a laser beam is
fired on the material. This causes the material to rise in a Taser-desorbed’ cloud of 
charged molecular ions -  both matrix and sample. This part of the procedure is the 
‘laser desorbtion ionisation,’ which is assisted by the presence of the matrix 
(Guptasarma, 2001).
At this point, a voltage is applied to a nearby giid that causes the charged molecules to 
rush towards it, in a manner dependant on the charge of the molecule, and the sign and 
magnitude of the voltage applied (Guptasaiina, 2001). The molecules accelerating 
towards the grid pass tlnough it, entering a high vacuum tube. As the variously sized 
molecules race through the tube, the time it takes each molecule to reach the end 
depends on the mass of the molecule. Thus, by recording the time of aiiival of ions, the 
time of flight can be estimated, and from this value the mass can be estimated 
(Guptasarma, 2001).
However, further fragmentation of the proteins is often required before they can be 
identified. Tandem mass spectrometry (MS/MS) induces further fragmentation of 
proteins, achieved by inducing ion/molecule collisions during ‘collision-induced 
dissociation’ (CID). The resultant fragments exist as a family of subset ions (e.g. amino 
acid chains) of the original parent ion (e.g. a whole protein). Computerised analyses of 
the m/z spectrum of these ions are used to obtain a fragment ion spectrum to gain 
stmctural information about the parent ion (Lesney, 2001).
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Peptide molecular weight measurements are predictive of amino acid structure, and 
peptide fragmentation information relates to amino acid sequence. Each set of 
information can be correlated to protein sequences in a database (Yates, 2000). The 
identity of an unknown protein is deteiinined by comparing the molecular weight map 
of the unlcnown protein with the theoretical molecular weights of peptides that are 
produced by digestion of each of the proteins in a database (Yates, 1996; Yates, 1998).
Sequencing the genome of an organism is now a major stepping-stone to understanding 
its biology. The data generated by a whole genome sequence has significant benefits in 
proteomics (Yates, 2000). The genome is the entire genetic make-up of an organism 
and contains all the infomiation for making specific proteins. Since the genome dictates 
the proteome, the genome-sequencing projects have played a major role in the advances 
of protein identification processes.
1.2.4 Proteomics and the nervous system
Proteomics has been used to study protein expression in the nervous system in several 
studies. One such major on-going project is using proteomics to study learning within 
the nervous system. For example, early studies, using glass capillary electrophoresis, on 
protein synthesis at synaptic junctions in the nervous system, with respect to learning, 
showed that activity in neiwe cells could lead to new protein synthesis (Hyden et al, 
1968; Hyden et al, 1969). However, the identity of these synaptic proteins was 
unlaiown, and it was not until modern protein sequencing teclmiques became available 
that their identity was revealed.
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By the late 1980s, 2D gel electrophoresis allowed the simultaneous analysis of many 
proteins associated with learning. Kandel and colleagues used ganglia from the sea slug 
{Aplysia california) to study proteins that change in level of expression following 
synaptic activity. They used 2D gels to suiwey and isolate proteins (Castellucci et al, 
1988; Sweatt et al, 1989). However, there were still limitations with the teclmique at 
this time and it was frequently the case that insufficient amounts of proteins were 
obtained for Edman sequencing. Edman sequencing is a sensitive method involving the 
sequential cleavage of amino acid derivative, one at a time, from the N-terminus of a 
protein (Edman and Begg, 1967). Other limitations with Edman sequencing include an 
upper mass limit and N-tenninal blocking. Proteins above lOOkDa are seriously limited 
with the amount of sequence that can be read, due to peptide bond cleavage arising 
mainly from N to O acyl shifts (Vensel and Tarr, 1995). Moreover, proteins with a 
chemically inaccessible alpha-amino group camiot be sequenced directly by this 
procedure and are tenned N-terminally blocked (Vensel and Tan*, 1995). It was not 
until the application of mass spectrometry that the sequencing of such small protein 
quantities was possible (Grant et al, 2001).
Improved quantitative methods are also valuable when investigating the levels of 
various proteins in complexes obtained from different starting materials, such as 
different regions of the mammalian nervous system, many of which are very small, 
especially within the brain. It is imperative to be able to utilise as much of each such 
sample as possible. Neural tissue often contains a high lipid content (the insulating 
myelin sheath surrounding nerves contains many lipids), as well as being fibrous due to
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the connective tissue (Grays, 34^’ Ed.). This adds to analytical problems by making 
solubilisation and protein extraction difficult. Fibrous tissues are physically difficult to 
homogenise and to extract proteins from, whilst the hydrophobic nature of lipids will 
resist solubilisation. Such complications may result in undesirable, low protein 
concentration sample mixtures. However, the advances in mass spectrometry and the 
ever updated protein databases means there are increasingly higher chances of 
identifying the proteins in question, despite these limitations.
Additional proteomic studies applied to the neivous system include Jenkins and 
colleagues’ (2002) study of the afreet of cortical impact on the hippocampus using 2D- 
E, Tilleman et al (2002) studied neurodegeneration in the brain of tau transgenic mice, 
also using proteomic methods for the analysis of brain tissue was Brookes et al (1990), 
Preobrazhensky (1993), Dey et al (1994), Abe et al (1997), Janke et al (2000), 
Oppermann et al (2000), Schonberger et al (2001), Fonstanze et al (2001), Castegna et 
al (2002), and Matsu-ura et al (2002). Proteomics was also used by Geschwind et al 
(1996) for the identification and characterisation of novel developmentally regulated 
proteins in rat spinal cord. Oblinger (1987) used 2D-E to study the characterisation of 
posttranslational processing neurofilament protein in vivo in dorsal root ganglia, 
Shimoji and colleagues (1999) studied nerve damage îoWovtmg Mycobacterium leprae 
invasion of Schwann cells, also in the peripheral nervous system, using proteomics. 
Cerebrospinal fluid (CSF) was analysed using proteomics by Sickmann et al (2002), 
Zerr et al (1996), and Green et al (2001).
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There has been very little proteomic research concerning autonomic ganglia and thus, 
there is limited Imowledge either on the protein expression in autonomic ganglia or on 
the methodology for sample preparations. One of the few examples of such a study was 
carried out on the trigeminal ganglia of rats during experimentally induced 
inflammation (Frisco et al, 2001). Using high resolution 2D-E and mass spectrometry 
in vivo and ex vivo, pro-inflammatory stimulation of rat trigeminal ganglia were studied 
as a model to analyse nociceptor protein changes during inflammation. A database was 
compiled containing a list of the proteins identified within rat trigeminal ganglia by 
MALDI-TOF-MS from the 2D gel (Frisco et al, 2001).
1.3 The autonomic nervous system
1.3.1 Introduction: Structure of the autonomic nervous system
thThe ANS has previously been described in detail, for a full explanation see Totora, 8 
Edition. Briefly, the autonomic neiwous system controls involuntary reactions to 
stimuli, thereby, regulating physiological functions. The autonomic nervous system 
(fig. 1.1) is divided into two major sections: sympathetic and parasympathetic. The 
afferent neiwes sub-sei*ving both systems convey impulses from sensory organs, 
muscles, the circulatory system and organs of the body to the controlling centres 
(medulla, pons and hypothalamus) in the brain. From these centres the efferent neiwes 
convey impulses to all parts of the body by the parasympathetic and sympathetic 
systems (Goldstein and Smith, http://www.ndrf.org/ans.html). Generally, the two 
systems have opposing effects on given bodily organs, one causing excitation and the
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other inhibition. The system s use different neurotransmitters and different
neurotransmitter receptors; this is the basis for dual innervation.
Figure 1.1. Diagrammatic structure of the autonomic nervous system. (From 
http://vanat.cvm.umn.edu/TFFIectPDFs/LectANS.pdf) The diagram shows the location 
of the cranial cervical ganglion (marked *) which was used in this study.
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1.3.2 Autonomie ganglia
Autonomie ganglia are discrete collections of postganglionic neurons of the 
parasympathetic and sympathetic systems. Autonomic ganglia are generally divided 
into three groups: two of which are components of the sympathetic division and one 
group is a component of the parasympathetic division. The neural cell bodies are 
centralised within the bulk of the ganglia, whilst the nerve fibres (axons/dendrites) are 
arranged in parallel bundles entering or leaving the body of the ganglion, where it 
narrows (Fig. 1.2,1.3). The ganglion is wrapped in a protective connective tissue 
sheath, or endoneurium (BhamBurkar and Prakash, 1992). Strands from the sheath 
extend into the parenchyma of the ganglion (BhamBurkar and Prakash, 1992).
Figure 1.2. External structure of a ganglion.
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Figure 1.3. internal organisation of an autonomic ganglion (adapted from Kiernan 
JA, 2002).
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1.3.3 Cranial cervical ganglia
The cranial cei-vical ganglion (superior cervical ganglion) is the largest of the tlmee 
ganglia of the cei*vical portion of the sympathetic tmnlc. In man, it is of a reddish-grey 
colour, and usually fusifomi in shape, sometimes broad and flattened. Within the 
ganglion, there are large extracellular spaces that contain collagen (DePace, 1981). The 
cranial cervical ganglion communicates with the cervical neiwes, some thoracic neiwes 
and with a select few cranial neiwes.
1.4 Aims and objectives
The aim of this investigation was to further our understanding of EGS by comparing 
protein expression, using proteomic teclmiques, in homogenates of cranial cervical 
ganglia collected from horses with acute EGS and from control horses. It was hoped 
that proteomic analysis would identify proteins that would contribute to our Imowledge
17
of physiological mechanisms of neuronal death that occurs in EGS and therefore, help 
determine the aetiology of the disease. The following objectives were met:
1.4.1 Development of sample preparation and optimisation of 2DE for equine 
autonomic ganglia
Ganglia were homogenised and the component proteins separated by high-resolution 
2D-E (Cohen et al, 2002). Cranial cervical ganglia where chosen because they 
consistently display a high proportion of damaged neurones as a result of EGS. Horses 
with acute EGS were selected in order to increase the chances of identification of the 
candidate neurotoxin. Since little proteomic work concerning autonomic ganglia had 
been carried out previously, much of this work was pioneering. The initial objective of 
the project was to create a method of optimising protein solubilisation and extraction 
from autonomic ganglia for optimal separation of the proteins. Homogenisation 
methods, protein amounts to load onto gels and the ideal pH ranges for first dimension 
separation, were some of the areas that were investigated in order to devise the most 
reproducible gels and then give the optimal chance of isolating EGS-related proteins.
1.4.2 EUmmatiiig natural variations in ganglia proteome expression
Due to the limited sample numbers and the samples that were obtained coming from 
animals that were not purpose bred (e.g. transgenic mice), it was considered likely that 
in this study there would be unavoidable differences in the protein expression between 
horses of differing breeds, ages and sexes. However, by identifying the proteins 
associated with these natural variations they could be eliminated from the analysis of
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EGS related proteins. Thus, comparisons of samples were made from (1) the same 
ganglia, (2) different ganglia from the same horse, (3) ganglia from different horses of 
the same sex, and (4) ganglia from horses of each sex to help eliminate variation 
unrelated to the development of EGS.
1.4.3 Identification of EGS related proteins
Quantitative comparison of the protein spot patterns on 2D gels of ganglia homogenates 
from EGS and control horses were carried out to isolate spots that appeared to be EGS 
related. Protein 'spots' that were consistently up-regulated or down-regulated in all EGS 
samples were removed from the gels and an attempt to identify them using MALDI 
mass spectrometry was made in the first instance. The proteins were identified by 
comparison against the fingerprints of all known protein sequences contained in a 
database. Considerable difficulty in characterising equine proteins was expected due to 
the limitations of the equine genome project and hence little information on equine 
proteins. The identity of candidate proteins for which there is no published sequence 
was further investigated using tandem mass spectrometry, to provide further 
information about the sequence of the protein(s) in question.
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Chapter Two: Optimisation of 2D-E analysis of equine 
autonomic ganglia
2.1 Introduction
Sample preparation is considered one of the most important steps for optimal 2D-E 
analysis. For example, the nature of the sample will determine the method of 
homogenisation. Frisco and colleagues (2001) used rat trigeminal ganglia for proteomic 
analysis and used a mechanical glass homogeniser, whilst Sickmann and colleagues 
(2002) had no need for mechanical homogenisation for their proteomic study using 
CSF; instead they suspended proteins in a modified reswelling (rehydration) buffer.
The buffers and additives (such as protease inliibitors) will also vary according to the 
type of sample used. The aim is to extract, solubilise and suspend the greatest quantity 
of protein from the sample without causing degradation to the proteins. A standard lysis 
buffer was used by Frisco et al (2001) and Jenkins et al (2002) to solubilise proteins 
fr om rat trigeminal ganglia and rat hippocampal cells, respectively. Geschwind et al 
(1996) homogenised their spinal cord sample in a Tris buffer containing pepstatin A 
and phenylmethyl sulphonyl fluoride (PMSF).
Therefore, the main aim of the first part of this project was to develop an optimal and 
reproducible sample preparation method that allowed simple and effective 
solubilisation of the proteins from equine autonomic ganglia for analysis by 2D-E. 
There are no published reports of autonomic ganglia from the horse {Equus caballus) 
being analysed by 2D-E gel electrophoresis, therefore, there are no recommended
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preparation procedures for the homogenisation of the tissue and solubilisation of the 
proteins.
The first task was to section the actual ganglia and remove the outer connective tissue 
sheath. By removing the sheath the possibility of inadvertent contamination from 
extraneous proteins, such as those present within contaminating blood and serum 
during post mortem collection would hopefully be eliminated. It was also anticipated 
that samples taken from each section would be standardised, by sampling a 
standardised region of the ganglion.
Neural tissue contains high quantities of lipid and fibrous components, especially 
within the dense collections of neuronal bodies such as ganglia. Such tissue may cause 
problems during the homogenisation and solubilisation of the proteins from the tissue 
for proteomic analysis. It was, therefore, proposed that a mechanical homogenisation 
method would be needed to render the material effectively.
ID mini-gels were run with autonomic ganglia samples to estimate the protein content 
and to check the efficiency of homogenisation. ID mini-gels are relatively inexpensive 
and quick to rtin, and hence, were ideal for such analyses.
Before a 2D mini-gel was run, a protein assay was performed to assess the protein 
content in autonomic ganglia preparations. The ganglia sample was then separated by 
2D-E on 7cm gels, once the protein content had been calculated and the size of sample 
needed for a 2D mini-gel had been established. This stage of the development of 
sample preparation allowed for assessment of the methods for use on a 2D gel, but
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without the expense in time and money that would be required for large format 2D-E 
analysis of protein expression.
The comparisons of sample preparation methods included running gels with 
DNAse/RNAse, determining the optimal protein-loading amount and comparing the pH 
ranges of first dimension lEF strips. A further investigation evaluated a cryogenic 
grinder, in an attempt to improve the extraction of proteins during homogenisation.
Aims
The aims of the work within this chapter were:
• To optimise the sectioning and homogenisation of autonomic ganglia for 
electrophoretic analysis
• To optimise ID mini-gels
• To optimise 2D mini-gels
• To assess the protein content of autonomic ganglia preparations
• To optimise large format (24cm) 2D gels
• To optimise the specifics of sample preparation for large format 2D-E by:
• Evaluating the advantage of DNAse/RNAse treatment
• Optimising protein loading quantities for 24cm 2D-E gels
• Detemiining the optimal pH range for protein analysis
• To explore the value of the cryogenic grinder for sample preparation
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2.2 Materials and methods
2.2.1 Collection and preparation of cranial cervical ganglia from Equus caballus
Cranial cervical ganglia were surgically removed from horses that had died or were 
euthanised due to EGS on post mortem, at the Royal (Dick) School of Veterinary 
Studies, Edinburgh. Immediately following collection, the cranial cervical ganglia (ccg) 
were frozen using liquid nitrogen and sealed in individual zip-top plastic bags, labelled 
with the ganglion ID and stored at -70°C until needed. The samples were transported to 
the University of Glasgow on dry ice to maintain their frozen state and preseiwe the 
protein composition of the tissue.
2.2.2 Sectioning of cranial cervical ganglia
Figure 2.1 shows how the frozen ganglia were cut and the connective tissue sheath 
removed, using a scalpel laiife, to prevent contamination with blood and serum. By 
weighing the sectioned ganglion, it was shown that, in general, a 1mm cross section of 
a whole ganglion would result in approximately 30mg of wet weight tissue suitable for 
use for proteomic analysis.
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Figure 2.1. Sectioning of autonomic ganglia for preparation for 2D-E to remove 
surface contamination and to standardise the site of sample collection.
([
1-2cm — ►
1mm.
a) Whole ganglion 
showing example 
incision-lines for 
sectioning.
b) Transection of 
ganglion (diameter ~ 
0.5cm) showing outer 
sheath and inner core. 
The outer sheath is 
removed.
c) The final product of 
a section of central 
ganglion ready to be 
homogenised for 
proteomic analysis.
2.2.3 Homogenisation of tissue
Ganglia were placed in eppendorf tubes with lysis buffer and using a scalpel knife were 
manually rendered, until an almost clear pulp resulted. The suspensions were then 
subjected to the following treatments:
• frozen in liquid nitrogen
• thawed in a heating block (no hotter than 30 °C)
• vortexed for 1 min.
repeated 3 times
The resulting solutions were then centrifuged (13,000 x g) to separate any remaining 
solid material. The supernatants were collected and centrifuged again before being used 
for 2D-E analysis.
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2.2.4 One dimensional SDS-PAGE using mini-gels
ID mini-gels were mn with samples from equine autonomic ganglia using the BIO­
RAD mini-PROTEAN II electrophoresis cell kit. Acrylamide gels were prepared and 
poured using a 15% resolving gel and a 5% stacking gel. Promega Broad Range protein 
marker (catalogue no. P7702S) and samples were loaded into wells in the stacking gel; 
the electrophoresis chamber was assembled and filled with SDS electrophoresis buffer 
according to the protocol. The gels were run at 120V, 300mA for -1.0-1.5 h.
2.2.5 Determination of protein concentration in equine autonomic ganglia
The protein content of sample of equine autonomic ganglia (pg/ml) was estimated 
using the Pierce BCA Protein Assay kit, following the microplate procedure. Briefly:
1.25 pi of each BSA concentration standard was pipetted into a microplate well and 
25 pi of each concentration of sample was pipetted into adjacent wells 
2.200 pi of the working reagent (WR) was added to each well and then thoroughly 
agitated on a horizontal plate shaker for 30 s
3.The plate was covered and incubated at 37°C for 30 min
4.The plate was cooled to room temperature
5.The absorbency was measured at or near 562 nm on the Titertek Multiscan® MCC/40 
microplate reader (Labsystems & Flow Laboratories, Finland)
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Table 2.1. Preparation of diluted albumin (BSA) standards. Dilution scheme for 
standard microplate procedure (Working Range = 20-2,000 pg/ml)
Volume of Diluent Volume and Source of BSA Final BSA Concentration
A 0 300 pi of Stock 2,000 pg/ml
B 125 pi 375 pi of Stock 1,500 pg/ml
C 325 pi 325 pi of Stock 1,000 pg/ml
D 175 pi 175 pi of vial B dilution 750 pg/ml
E 325 pi 325 pi of vial C dilution 500 pg/ml
F 325 pi 325 pi of vial E dilution 250 pg/ml
G 325 pi 325 pi of vial F dilution 125 pg/ml
H 400 pi 100 pi of vial G dilution 25 pg/ml
I 400 pi 0 0 pg/ml = Blanl<
2.2.6 2D mini-gel of equine autonomic ganglia
2D mini-gels provide a good way to practise the relevant steps of running 2D-gels 
without the expense of the large format gel, 2D mini-gels are also a good indicator of 
protein content and sepai'ation that would be present on the large format gels.
The Amersham Pharmacia Biotech 2-D Electrophoresis protocol was followed to run 
equine autonomic ganglia sample though 2D SDS-PAGE. Briefly, 125pi of the 
complete rehydration solution, containing the sample, DTT and JPG buffer, was applied 
along the strip holder and a 7cm pH4-7 IPG strip was used. The strip was left to run 
tlii'ough rehydration in the Amersham IPGphor equipment (a minimum of 10 h), and 
Isoelectric Focusing (lEF) at about 8000V and very low currents until it had reached 40 
000 Volt-hours (V-h), as recommended.
The strips were then equilibrated with SDS buffer and DTT on a horizontal agitator 
(e.g. the ADLOF KÜHNER AG, SCHWEIZ, Lab-Shaker) at 40min^ for 15 min. The 
strip was then applied to a Bio-Rad mini-gel (set up prior to equilibration and as
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described for ID mini-gels, but with no need for a stacking gel). The gel was then left 
to mn tlirough second dimension electrophoresis, again as for ID mini-gels.
2.2.7 Coomassie Brilliant Blue staining for 2D-E gels
• Each gel was placed in a staining tray and completely submerged with Coomassie 
Brilliant Blue staining solution.
• The staining trays were covered and left on a lab agitator for 1-3 days.
• The background staining was removed by submerging the gels in a de-stain
solution (10% acetic acid/ 40% methanol) that was changed every couple of
hours, until the desired contrast had been obtained.
2.2.8 Silver-staining for 2D mini-gels
The standard protocol for the Amersham Pharmacia Biotech, protein silver staining kit 
was followed:
Fixation; 100ml ethanol, 25ml acetic acid and made up to 250ml with deionised
FlzO, the gels were covered and left on the Lab-Shaker for 30 min.
Sensitisation: 75ml ethanol, 10ml glutaraldehyde, 10ml sodium thiosulphate, 1 sachet 
(17g) sodium acetate and made up to 250ml with deionised H2 O, the 
gels were covered and left for 30 min.
Washing: the gels were rinsed and washed with deionised H2 O 3 times for 5 min.
Silver reaction: 25ml silver nitrate solution, 0.1ml formaldehyde and made up to 
250ml with deionised H2 O.
Washing: the gels were rinsed and washed with deionised FI2 O 2 times for 1 min.
Developing; 1 sachet (6.25g) sodium carbonate, 0.05ml formaldehyde and made up to 
250ml with deionised FI2 O. The gels were covered until developed to 
suitable level (approx. 2-5 min).
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Stopping: 1 sachet (3.65g) EDTA-Na2*2 H2 O and made up to 250ml with
deionised H2 O, and added to gels as soon as developing was complete.
Washing: the gels were rinsed and washed 3 times for 5 min with deionised H2 O.
Preserving: 75ml ethanol, 11.5ml glycerol (87%) and made up to 250ml with
deionised H2 O. The gels were covered and left for 30 min. Repeat.
2.2.9 Sypro-Ruby staining for 2D-E gels
• The gels were fixed in 10% methanol/7% acetic acid for 30mins whilst on the 
Lab-Shaker
• The gels were then stained in Ruby Gel stain (10 x volume of gel) for at least 3 h 
or overnight
• Finally the gels were rinsed in 10% methanol/7% acetic acid for 30-60 min to 
reduce background fluorescence
2.2.10 Sypro-Orange staining for 2D-E gels
• The proteins were fixed in the gel using 10% MeOH/7.5% acetic acid on the Lab- 
Shaker for 1 h.
• Probed using 0.05% SDS for 1 h
• Stained with SYPRO-Orange with gentle rocking overnight (making sure that no 
light gets into the gel.)
• De-stained with 30% methanol/ 10% acetic acid for ~1 min, pre-scan, and repeat 
de-staining until the desired contrast has been achieved.
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2.2.11 Colloidal Coomassie Blue staining for 2D E gels
• A 5% Coomassie stock (5g/250ml) was made up.
• The colloidal stock was made up (50g ammonium sulphate, 500ml H2 O, 6ml 
phosphoric acid, 10ml Coomassie stock)
The stain was made to the following ratio: 1 part methanol, 4 parts colloidal stock 
The gels were fixed for 2 h in 40% ethanol/10%acetic acid 
The gels were then washed twice for ten min in H2O 
The gels were stained for 1-7 days 
The gels were de-stained by rinsing with H2 O
2.2.12 Large format (24cm) 2D-E gels of autonomic ganglia
The large format 2D gels are based on the same principles and procedures as the 2D- 
mini-gels. Large gels allow for the separation of proteins over a larger area, therefore, 
making analysis of protein spots easier. The large format pre-cast, plastic-backed gels 
(Amersham Phannacia Biotech) are also compatible with the Ettan Spot-picker robot 
and subsequent mass spectromic analysis.
Using the Amersham Pharmacia Biotech protocol as a guide, sample solution was 
loaded into 24cm strip holders and strips placed in each holder. The strips were run at 
8000V, requiring a minimum of 70 000 V-h to be reached for optimal focusing of 
protein spots. During the second equilibration step, pre-cast gels supplied by Amersham 
Pharmacia Biotech were used. Once electrophoresis was completed the gels were 
Coomassie brilliant blue stained over night.
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2.2.13 Comparisons of sample preparation methods -  optimising 2D-E gels of 
equine cranial cervical ganglia
2D-E gels were mn to determine the optimum sample preparation methods and adjust 
the 2D-E techniques to produce the best quality gels:
• Comparing of gels with sample, with and without DNAse/RNAse treatment
• Comparing gels with different amounts of protein loaded onto lEF strips
• Comparing gels of different lEF strip pH ranges
2.2.14 Novel sample preparation methods - using a cryogenic grinder
Cryogenic grinders have generally only been used for the degradation of hard materials 
such as hair and nails for forensic analysis. These grinders reduce such materials to a 
fine powder by freezing them in liquid nitrogen and subsequently hammering them 
within a small, cylindrical chamber with a pellet at an extremely high frequency. It was, 
therefore, considered worthwhile to investigate whether the ganglia could be reduced to 
a smooth liquid pulp in this manner and thus aid the solubilisation of the proteins.
Homogenisation of equine autonomic ganglia with the cryogenic grinder was kindly 
provided by the Department o f Forensics at the University of Glasgow (supervised by 
Dr Robert Anderson). 45 mg of wet weight sample was loaded into the chamber and 
the pellet inserted. The chamber was placed in the cryogenic grinder and the entire 
equipment was filled with liquid nitrogen. The sample was ground at an automated 
setting, 1 minute of pulping followed by 1 minute of rest/re-freezing and another 
minute of pulping.
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2.3 Results
2.3.1 ID Mini“gel: comparing ganglia with and without sheath
This experiment had two purposes. The first was to determine whether the amount of 
protein in the size of sample used was adequate for electrophoretic analysis. The second 
was to examine the extent of inadvertent contamination of the proteins caused by the 
inclusion of the outer comiective tissue sheath of the autonomic ganglia. The ganglia 
were sectioned as previously described for sample 1. A second sample was also 
sectioned off, but left as an intact disc of ganglia with the outer comiective tissue sheath 
remaining.
Figure 2.2 shows that the gel contained an adequate amount of protein for 
electrophoretic analysis, as illustrated by the clear and distinct banding of the separated 
proteins. It also appears there was little difference between having removed the 
comiective tissue sheath and leaving it intact. However, this could not be guaranteed for 
each case, and therefore, the sheath was removed from all samples thereafter.
Using the protein marker ladder, the logio of the molecular weight of the protein bands 
of the ladder was plotted against the distance of the dye migration, allowing the 
molecular weights of the protein bands to be estimated. The following relationship was 
employed (Table 2.2):
Rf = distance of protein migration/distance of dye migration
Weight (kDa) Logio mol weight Rf
116 2.064 0.079
66.4 1.822 0.239
42.7 1.63 0.389
26.6 1.425 0.602
14.3 1.155 0.893
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Graph 2.1. Logio of molecular weight of marker bands plotted against Rf, used to 
calculate the relative weights of protein bands.
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Figure 2.2. 1D Mini-gel of autonomic ganglia homogenate showing the relative weight 
markers (kDa) calculated from graph 1. (a) 10pl sample without surface connective 
tissue sheath (b) 10pl sample with surface connective tissue sheath.
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42.7
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2.3.2 Determination of protein concentration in autonomic ganglia
The protein content of a typical sample of equine autonomic ganglia (~30mg wet 
weight tissue, homogenised in lysis buffer) was estimated using the Pierce BCA Protein 
Assay kit, a detergent-compatible fonnulation based on bicinchoninic acid (BCA). 
Protein concentrations were determined with reference to standards of bovine semm 
albumin (BSA).
The microplate procedure was used for ease of sample handling with a microplate and 
the smaller volume (10-25 pi) of protein sample required. Table 2.1 was used as a 
guide to prepare a set of protein standards. A series of dilutions of known concentration 
were prepared from the standard protein and assayed in parallel with the unknown 
(equine autonomic ganglia) samples. The microplate was then covered and incubated at 
37°C for 30 min. Once cooled to room temperature, the absorbency was measured at 
~562nm using a Titertek Multiscan microplate reader and software. The protein 
concentration of ~30mg of wet weight equine autonomic ganglia was determined based 
on a standard curve.
Initially it was found that the protein samples were of too dark a colour to measure the 
absorbency, indicating that either the protein concentration was too high (exceeding 
2000pg/ml) or the sample contained lipids or lipoproteins. The experiment was 
therefore repeated using samples diluted to 1:5, 1:10 and 1:20. This appeared to solve 
the problem and good readings of absorbency were obtained and the protein 
concentration determined.
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Table 2.3. Protein assay results and standards.
Sample ID (OD) Data (OD) Mean Concentration (pg/ml)
T1 over over * * * * *
12 1.457 1.457 310
13 1.048 1.048 150
14 1.830 1.830 603
S1 over over 2000
S2 over over 1500
S3 2.452 2.452 1000
84 2.078 2.078 750
S5 1.449 1.449 500
S6 1.154 1.154 250
S7 0.682 0.682 125
S8 0.309 0.309 25
Where T = tested sample
S = standard sample 
OD = optical density
Graph 2.2 Protein Assay Standard Curve
OD Versus Concentration
OD 3.000
2.500
2,000
1.500
1.000
0.500
0 000
1000 000 3162.278316.228100.00031.623
Concentration ( pg/ml )
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The protein content of 30mg wet weight tissue was calculated as follows:
25]i\ of 30mg of ganglia in 200pl of diluted (1:5) lysis buffer = neat protein sample 
( 1:1).
In sample dilutions 1:5 the protein cone" = 602.906pg/ml 
1:10 “ “ = 309.852pg/ml
1 : 20 “ “ = 149.275pg/ml
=> The mean protein cone" = (602.906x5 + 309.852x10 + 149.275x20)
3
= 3032.85pg/ml
->  In 30mg of ganglia homogenised in 200pl of diluted (1:5) lysis buffer there is a 
protein concentration of ~ 3033pg/ml
606.6pg protein in 200pl of homogenised tissue 
0.606mg of protein in 30mg of wet weight tissue 
^  2pg of protein in ling of wet weight tissue.
2.3.3 2D mini-gel of equine autonomic ganglia
A 2D mini-gel, of homogenate from equine autonomic ganglia 02/852 was run with 
125pi of rehydration solution, also containing DTT. The Amersham Pharmacia Biotech 
protocol was followed, using a 7cm, pH4-7 strip, to rehydrate and run through lEF 
overnight.
The strip was equilibrated twice in equilibration buffer containing DTT and 
iodoacetamide (lAA) for 15 min each, in preparation for second dimension 
electrophoresis. The BIO-RAD mini-gel equipment was set up as previously described. 
The gel was run tlnough electrophoresis for 1.0-1.5 h until the dye front had reached 
the bottom of the gel at which point it was removed from the electrophoresis apparatus 
and placed in a staining tray and Coomassie stained overnight.
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This mini-gel was the first 2D~gel performed using equine autonomic ganglia and so it 
was particularly useful in detemhning optimum sample preparation methods. The gel 
did clearly have protein on it, although there was a lack of focusing possibly due to 
excess protein, poorly homogenised or solubilised sample or poor technique. Data not 
shown.
2.3.4 2D mini-gel comparing protein spots of samples from ganglia from different 
horses
Two 7cm strips were run with the aim of comparing two samples of equine autonomic 
ganglia from 1) a control horse without grass sickness and 2) a horse with sub-acute 
grass siclmess. Strip 1 was mn with 125pl of rehydration solution containing DTT and 
sample from control autonomic ganglia 02/852. Strip 2 was run with 125pi of 
rehydration solution, also containing DTT, but with a sample from AGS autonomic 
ganglia 02/431. The Amersham Pharmacia Biotech protocol was followed using 7cm, 
pH4-7 strips and the strips left to rehydrate and mn tlnough lEF overnight.
The strips were equilibrated twice in equilibration buffer containing DTT and 
iodoacetamide (lAA) for 15 min each. The BIO-RAD mini-gel equipment was used. 
The gels were run tlnough electrophoresis for 1.0-1.5 h. The gels were then removed 
from the electrophoresis apparatus and placed in staining trays and Coomassie stained 
overnight. The gels were subsequently silver stained to improve the visualisation of the 
protein spots.
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The silver stained gels were satisfactorily focused (fig 2.3), with significant quantities 
of protein present and fairly good focusing of protein spots. However, the stain was 
slightly over developed and therefore, the images were excessively dark. The gel 
containing sample from the autonomic ganglia 02/852, was damaged with over­
handling during the relatively lengthy silver-staining procedure used (data not shown).
2.3.5 Large format (24cm) 2D-E gel of autonomic ganglia
As for 2D-mini-gels, Im nf slices of autonomic ganglia were taken, from the control 
ganglia 02/852 (sample 1) and 02/431 (sample 2), the sheaths removed and the 
remaining ~30mg of tissue were mechanically homogenised in lysis buffer (200pl), 
centrifuged and the supernatants collected into individual aliquots. 3 00pi of rehydration 
buffer, containing DTT and the appropriate IPG buffer, was added to each sample 
solution. The strips were left to run tlirough rehydration and lEF over night.
Following lEF, the strips were equilibrated twice, with DTT then lAA, on the Lab- 
Shaker for 15 min. During the second equilibration step, pre-cast gels supplied by 
Amersham Pharmacia Biotech were positioned on the gel cassettes as instructed. The 
strips were then rinsed in electrophoresis buffer and applied to the top of the large gels 
and sealed in place with 0.5% agrose sealing solution. The gel cassettes complete with 
gels and strips were placed in the Ettan Dalt II electrophoresis tanlc and left to run 
tlu'ough second dimension over night using the electrophoresis buffer kit supplied by 
Amersham Pharmacia Biotech.
Once electrophoresis was completed the gels were placed in staining trays and 
submerged in Coomassie brilliant blue stain over night. The gels were de-stained (30%
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methanol/ 10% acetic acid) until an adequate contrast was obtained; at which point the 
gels were scamied onto computer using the Amersham Pharmacia Biotech Light 
Scanner and Labscan software.
The gels were very faint with some minor streaking, thought to be caused by 
insufficient protein loading. Data not shown. This experiment was repeated. The same 
poor quality gel, with faint markings and slight streaking was obtained (data not 
shown), suggesting that there was an inadequate amount of protein loaded onto the gels. 
It was considered that a more sensitive method of staining (e.g. silver staining) might 
alleviate the problem.
The same experiment was repeated again, this time using ~60mg of wet weight tissue, 
resulting in far more protein appearing on the gel (Figure 2.4). However, the gel was 
very streaky and poorly focused. Subsequently, a sample preparation method using 
DNAse/RNAse was employed in an attempt to alleviate some of the streaking.
2.3.6 Comparison of sample preparation methods -  with and without 
DNAse/RNAse treatment
The previous gels showed adequate protein; however, the gels were very streaky and 
not properly focused. In an attempt to remove the streaking and improve the focusing of 
spots, comparative sets of gels were run. One gel was run with sample that was 
prepared in the usual mamier, whilst the other gel was run using sample was run 
incorporating DNAse/RNAse treatment.
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Following completion of both dimensions, the gels were washed in 10% methanol and 
7% acetic acid for 30 min, before staining with Sypro-mby over night. The Sypro-mby 
was poured off and the gels were de-stained (10% methanol and 7% acetic acid). The 
gels were then scanned using the Typhoon scanner.
The gel run with sample containing DNAse/RNAse treated sample was somewhat 
clearer (figure 2.5, (b)) and more focused than the gel without DNAse/RNAse (figure 
2.5, (a)). However, the use of DNAse/RNAse had still not completely solved the 
problem, as the gels were not focused and contained high levels of streaking and 
coagulations of protein spots.
2.3.7 Determination of optimal protein loading quantity
Despite the use of DNAse/RNAse the gels were still very streaky and unfocused, 
possibly due to a problem with the quantity of protein loaded onto the gels. Some gels 
did not contain enough protein (if ~30mg wet weight tissue used, equating to 600pg 
protein), whilst others had too much protein loaded (~60mg wet weight tissue used, 
equating to 1200pg protein) on them. It was, therefore, a logical progression to 
compare several protein loads to determine the optimal content required foi a good gel 
image with optimal spot intensity and minimal streaking.
Sections of ganglia were collected, as described, from ganglia 02/431. Sample 1 
weighed ~45mg wet weight tissue (—900pg protein), and sample 2 —60 mg wet weight 
tissue (~1200pg protein). Each sample was prepared and the proteins sepaiated by 2D- 
E as previously described. The gels were then stained with SYPRO-Orange following 
the standard protocol.
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From the images (Figure 2.6) it can be seen that the gels had adequate protein and good 
focusing. Using pH4-7 strips (as used with the mini-gel system) seemed to make a big 
difference, as both quantities of protein produced good gels, however, the gel with 
-900pg protein (-45mg wet weight tissue) was the clearest gel and showed the least 
streaking.
The experiment was repeated to check the reproducibility of these gels. This time, 
18cm gel strips were used and the sample weights reduced proportionately, otherwise 
the protocols remained the same. The gels produced (Figure 2.7) were comparable to 
the previous gels (Figure 2.6) and validated the reproducibility of the system.
2.3.8 Determination of optimal pH range
Having run several 2D gels with little separation of proteins occumng; the pH range 
used was revised. Gels with a range of pH 3-10 linear (figure 2.8) appeared not to be 
separating the proteins adequately. Therefore, to establish the most appropriate pH 
range to use for 2D gels, a comparison between pH4-7 (as successfully used in the 2D 
mini-gels and previously in 24cm 2D gels) and pH3-10 non-linear was set-up. Non­
linear pH strips over-represent the middle pH range in contrast to a linear pH gradient 
strip. Two -4 5 mg sections of ganglia (02-889) were collected and prepared for 2DE. 
pH4-7 strips were used with sample 1 and pH3-10NL strips with sample 2.
For the purposes of this project, using pH4-7 IFF strips was more effective. On 2D-E 
gels using pH4-7 strips in the first dimension, more spots were seen and better 
separation of proteins occun*ed than on gels using the pH3-10 strips. The proteins that
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were not separated using pH4-7, i.e. those with isoelectric points of pH3-4 and pH7-10, 
can be studied using specialised strips that cover the required range if  required.
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Figure 2.3 A silver-stained, 2D-E mini-gel of equine autonomie ganglia 02-431.
Figure 2.4. A Coomassie Blue stained, 2D-E large format gel of 60mg wet weight 
autonomie ganglia/1200pg protein, using a pH3-10 linear (L) lEF strip. The arrows 
highlight overloading of protein/unfocused protein.
£H 10
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Figure 2.5. A comparison of sample preparation methods for 2D-E analysis of equine 
autonomic ganglia (b) with and (a) without DNAse/RNAse treatment. These gels were 
Sypro-ruby stained. The red arrows indicate unfocused protein, green arrows indicate
focused protein.
pH3 pH10
f
(a) no DNAse/RNAse
(b) lOpl DNAse/RNAse
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Figure 2.6. Two 24cm, pH4-7, Sypro-orange stained, 2D-E gels comparing sample sizes of
equine autonomic ganglia to determine the optimal separation and focusing of proteins.
pH4
I
pH7
(a) 45mg tissue/900|Lig protein
T
II(b) 60mg tissue/1200pg protein. This gel shows more streaking and less focusing of 
protein (arrows) due to overloading with sample.
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Figure 2.7. Two 18cm, pH4-7, Sypro-orange stained, 2D-E gels assessing the
reproducibility of sample preparation methods and optimal sample sizes.
pH4
(a) 30mg tissue/600pg protein. This gel shows good focusing and 
plenty of protein, but some streaking.
■11 - ' y '
L
"I
H7
f
(b) 15mg tissue/300pg protein. In comparison, this gel shows lower 
numbers of protein spots, but good focusing and little streaking.
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Figure 2.8 Two 24cm, Colloidal Coomassie Blue stained, 2D-E gels run to compare 
1ER strips of different pH ranges for optimal separation of proteins. 
pH4     PH7IIII Ilium
$
\
(a) The pH4-7 lEF strip results in good separation of proteins and well focused spots.
(b) On the other hand the pH3-10NL lEF strip results in good focusing but the proteins 
are less separated making it more difficult to distinguish individual spots.
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Figure 2.9. Two 24cm, pH4-7, colloidal Coomassie Blue stained 2D-E gels run to 
assess homogenisation methods (a) using cryogenically ground tissue (b) using
manually homogenised tissue.
pH4 pH7
 ’ t f .  -  -,
♦  ♦
T
(a) cryogenically ground tissue. This gel has limited protein appearing on it because o f  
the unavoidable dilution o f  the sample. However, using the cryogenic grinder has 
extracted more protein than the conventional homogenisation method, see below.
%
f
(b) Conventional sample preparation method. This gel is less focused and has poorer 
extraction o f  proteins than the gel run with cryogenically ground tissue.
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23,9  Using a cryogenic grinder
Despite great improvements in gel quality following DNAse/RNAse treatment and 
optimising protein concentration and pH ranges, there remained the possibility that the 
tissue was not being adequately homogenised so the use of a cryogenic grinder was 
investigated.
Samples were processed by the cryogenic grinder as described in materials and 
methods and the resulting homogenate analysed by 2D-E. Sample 1 contained ~45mg 
wet weight equine autonomic ganglia that was ciyogenically ground and rinsed off the 
grinder with 200pi lysis buffer. However, there was insufficient liquid to remove all the 
pulped tissue so water was subsequently used, meaning the final sample solution also 
contained 1ml of HPLC grade H2O. Sample 2 contained ~45mg of manually 
homogenised equine autonomic ganglia, as in previous experiments, in 200pi lysis 
buffer. 1ml of H2 O was also added to sample 2 to keep the protein concentrations equal. 
The samples were separated using 2D-E, stained and scanned.
Both gels showed inadequate protein, presumably due to the excessive dilution of the 
samples. However, it was still possible to see more focusing and less unsolubilised 
material on the gel containing cryogenically ground sample. To confirm this, the gels 
were re-stained with colloidal Coomassie blue, a more sensitive stain to aid 
visualisation, and therefore, analysis (Figure 2.9).
However, due to the need for excessive dilution of samples during collection of 
rendered sample, it was decided that the manual homogenisation method would be 
more suitable for the purpose of this study.
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2.4 Discussion
There has been no published work covering the proteomic analysis of equine neural 
tissue. This combined with the fibrous and lipid properties of autonomic ganglia made 
the homogenisation and extraction of proteins challenging. Thus, a protocol for sample 
preparation and optimal running conditions for equine cranial cervical ganglia for 2D-E 
had to be developed. From the comparative experiments conducted throughout this 
chapter, an optimal protocol for 2D-E was developed for equine cranial cervical 
ganglia.
Following the protein assay (section 2.3.3) and gels comparing the different sample 
sizes loaded onto them (section 2.3.8), a section of equine autonomic ganglia weighing 
approximately 45mg was found to be the optimal weight to allow 900pg of protein to 
be run on the 24cm 2D-E gel. This also agrees with the protocol supplied by Amersham 
Pharmacia Biotech, which suggests a maximum of Img of protein should be loaded 
onto 24cm 2D-E gel strips. This optimal loading amount allowed for the greatest 
intensity of spots with minimum streaking.
The outer connective tissue sheath of the ganglia section was removed to prevent 
inadvertent contamination fi-om blood and serum picked up during post mortem and 
surgical collection of the equine autonomic ganglia. Jenkins and colleagues (2002) also 
considered that contamination may present a problem and consequently washed all 
hippocampi in cold isotonic saline before preparation for 2D-E analysis. The section of 
ganglia was then manually homogenised in an eppendorf tube containing 200pi of lysis 
buffer, using a scalpel knife, interspersed with 30s periods of vortexing until an almost 
clear pulp resulted. There was nearly always some fibrous material remaining in
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suspension due to the fibrous nature o f autonomic ganglia. Therefore, another method 
of homogenisation was investigated (e.g. using a cryogenic grinder, section 2.3.10) but 
the simplicity o f manual homogenisation with the scalpel knife, and complications with 
collection of homogenised sample fi-om the grinder, meant the original manual method 
was favoured. If this project were to be followed up, it would be worth investigating the 
value of a Bounce homogeniser, which was favoured by Geschwind and colleagues 
(1996) and Preobrazhenzky (1992).
To aid the solubilisation of protein fi-om the ganglia, the homogenised suspension was 
frozen in liquid nitrogen, thawed on a heating block and then vortexed, this procedure 
was repeated three times. Geschwind and colleagues (1996) used a similar freeze-thaw 
method in their sample preparation, during proteomic analysis of rat spinal cord. This 
freeze-thaw procedure was tried with five repetitions but little improvement was seen 
after three repetitions. The resultant solution was centrifuged to separate any remaining 
solid material and the supernatant was collected. To prevent interference with the 
absorption and separation of proteins into the first dimensional IPG strip, the 
supernatant was also then centrifuged.
For optimal focusing of proteins in the first dimension, DNAse/RNAse was added to 
the lysis buffer during homogenisation (section 2.3.7). The use of DNAse/RNAse 
during the sample preparation is also commonly seen in other proteomic studies of 
neural tissues, for example Frisco et al (2001) and Jenkins et al (2002), Thus, 150pl of 
the supernatant, containing DNAse/RNAse, were added to 300pl of rehydration buffer 
containing DTT and IPG buffer in all subsequent gel preparations. The pH of the IPG 
buffer should always correspond to the pH of the IPG strip used, thus, IPG buffer pH4-
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7 was always used since it was concluded that an IPG first dimension gel strip of pH4-7 
produced optimal separation of proteins on the 2D gel (2.3.9). Therefore, 450pl o f a 
solution containing sample and rehydration buffer, with the necessary additives, was 
pipetted into the 24cm strip holder and the strip laid on top followed by dry-strip cover 
solution and the holder lid. The strips were left for approximately 24 h on the IPGphor 
to rehydrate (10 h) and followed by lEF at 8000V until a minimum of 70 000Vh had 
been reached. Following lEF, the strips were first rinsed in equilibration tubes 
containing equilibration buffer with DTT added to saturate the strips with SDS, creating 
an overall negative charge in the proteins. This eliminates the effect of the charges of 
the proteins during separation by their molecular weight, and helps the gel firont to mn 
evenly. A second equilibration step was performed with equilibration buffer containing 
LAA. This step allows the gel to be compatible with the Ettan Spot-picker Robot and 
prevents the proteins from re-oxidising and minimises the reactions of cysteine residues 
(Cohen, 2002). The strips were briefly rinsed in cathode buffer to remove oils before 
being applied to the top of the 24cm pre-cast gel and sealed in place with a 0.5% 
agarose sealing solution. The gels were then mn in an Ettan Dalt electrophoresis tank, 
using the buffer kit system, for approximately 22 h or until the gel front reached the 
bottom of the gel.
The gels were stained with colloidal coomassie blue (see section 2.2.7) for improved 
sensitivity and simplicity of staining procedure and scanning o f the gel. Coomassie blue 
was a simple staining procedure; however, it was not nearly as sensitive as colloidal 
coomassie blue and would not pick up on some of the less concentrated proteins on the 
gels. Sypro stains were very sensitive, but they are expensive and require the use of a 
fluorescence scanner, such as the Typhoon scanner, which is time consuming. Silver
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spectrometry and, therefore, was not a suitable method if further analysis of the gel was 
needed. The protocol for silver staining is also very time consuming and quite complex, 
with many steps. Therefore, colloidal coomassie blue, which is a sensitive stain, 
compatible with the light scanner, spot-picker and MS, and had a simple procedure, 
was the most efficient stain used.
By using the established procedure described above, the best and most reproducible 
gels were obtained: optimal focusing of protein spots, minimisation of streaking, and 
high resolution of protein content allowing for further analysis of the gel.
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Chapter Three: Evaluating natural proteome variations and 
assessment of MALDI-MS for the characterisation of equine 
proteins
3.1 Introduction
3.1.1 Equine genome variation
Genetic vaiiation occurs between different individuals and breeds of horse. Since genes 
encode for specific proteins, it is also likely there will also be a considerable variation in the 
protein expression between such horses and groups of horses. Blood typing and DNA 
typing have been used to evaluate intra- and inter-breed genetic diversity in horse breeds 
(Kelly et al, 2002). Kelly and colleagues used variations in blood groups, biochemical 
polymoiphisms and microsatellite loci to characterise Uruguayan Creole horses. They also 
investigated the phylogénie relationship among Creole breeds, their ancestor breeds and 
other American horse breeds. Data fi-om this study provided evidence for considerable 
genetic variation within Uruguayan Creole horses and of a distinctive breed profile. This 
suggests it could be possible that there is a significant differentiation in protein expression 
between all horses of the same breeds, for example, if  they are of different sexes or ages. 
Even horses of the same breed, sex and age can display differences in gene maps -  if they 
are different colours. For example, the colour locus, referred to as C in the horse, is linked 
to microsatellite markers on horse chromosome 21. Alleles of the horse colour locus (C) is 
thought to control the colour dilutions seen in the body colour o f horses (Locke et al, 2001). 
Such genetic variations could make the identification of a specific protein that is disease 
related difficult, as there could be an extensive variation between the proteomes of horses, 
even prior to disease related changes.
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Another potential variable worth considering is the change in protein expression along the 
length of each ganglion. The cellular components along the length of the ganglion could 
vary with position. For example, at the ends of the ganglion are channels of axons and 
dendrites, whilst neural cell bodies will be located centrally in the ganglion (fig 1.3). These 
are all factors that had to be recognised throughout this project as fiiere is little that can be 
done to avoid such variations, especially given the low sample numbers available. This 
chapter was aimed at investigating these unavoidable genetic variations and how they affect 
comparative experiments with regards to diseased and non-diseased tissue samples.
3.1.2 Using MALDI-MS for the characterisation of equine proteins
Little work has been carried out on the equine genome and hence there is limited 
information contained within the protein fingerprint databases (e.g. NCBI). Therefore, the 
efficiency of MALDI-MS will be limited with respect to identifying equine autonomic 
ganglia proteins. The only proteins identified, as equine proteins were those that had 
previously been characterised and their information stored. However, other proteins may 
well be recognised but matched to those belonging to a different species. Provided there is 
homology between the species and Equus caballus the match could be considered 
successful.
3.1.3 Aims
To investigate the extent of variation seen on 2D-E gels, between:
• Samples taken from different locations along the length of the same equine
autonomic ganglion
• Samples taken from different ganglia from the same horse
• Samples taken from ganglia fi"om different horses of the same sex
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• Samples from horses of different sex 
To investigate the efficiency o f MALDI-MS for the characterisation of equine 
autonomic ganglia proteins.
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3.2 Materials and methods
3.2.1 Determination of variations in ganglionic protein expression
Sets of 2D-E gels were run, as previously described, to analyse the differences in 
protein expression between:
• Different sections taken from along the length of the same ganglion (Fig 3.1)
• Different ganglia from the same horse
• Ganglia from different horses of the same sex
• Ganglia from horses of different sexes
• Ganglia from horses with AGS and control horses
Figure 3.1 Sections of ganglia cut to determine whether there is any significant 
variation in the protein expression along the length of the ganglia.
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3.2.2 Evaluating the effectiveness of 2D-E for comparison of EGS affected ganglia 
and control ganglia
2D-E gels were run, using the optimal method developed in Chapter Two, to compare 
the protein expression of EGS affected ganglia with that of control ganglia.
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3.2.3 Evaluating MALDI-MS for the characterisation of equine proteins
A 2D-E gel was mn and a picklist made using the ImageMaster analysis software 
(Amersham Pharmacia Biotech). The spots picked and an in-gel trypsin digest was 
carried out by the Ettan Spot Picker Robot. The peptide fragments were then 
presented to the PerSeptive Biosystems Voyager DE-STR MALDI-MS. The acquired 
peptide mass fingerprint spectra were compared to known peptide spectra contained 
within databases to identify unknown proteins.
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3.3 Results
3J3.1 Comparison of protein expression along the length of ganglia
To determine the extent of variation of protein expression along the length of the ganglia, a 
series of sections were cut from a ganglion as shown in Figure 3.1. The proteins in these 
sections were then separated using 2D~E and the gels analysed in order to identify any 
maj or differences in the protein expression.
Six sections of the control autonomic ganglion 01-681 were sliced from one end of the 
ganglion and labelled 1-6 respectively (fig 3,1). The samples were run simultaneously 
through 2D-E, as described in the previous chapter, to separate the proteins. On completion 
of electrophoresis, the gels were stained in Colloidal Coomassie brilliant blue over night 
and scanned using the Amersham Pharmacia scanner and Lab scan software.
From the gels in figure 3.2, it could be seen that there was little significant difference in the 
protein expression of samples taken from each position along the length of one ganglion. 
Any differences that were visible were perhaps due to minor differences in sample sizes 
causing some material to remain unfocused. Also, there were some wavy sections in the 
gels, through uneven mnning, that may have been caused by the electrophoresis buffers in 
the tank not circulating adequately.
33 .2  Comparing the protein expression of ganglia from the same horse and from 
different horses.
The variation in protein expression between the two (left and right) cranial cervical ganglia 
from the same horse and subsequently two autonomic ganglia each from different horses
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were determined. Sections of ganglia were cut from both ccgs from the horse 02-56 and one 
section from ccg 01-681. The proteins in the samples were then separated by 2D-E. The 
gels were stained in Colloidal Coomassie brilliant blue and scanned using the Amersham 
Pharmacia scanner and Labscan software.
Figure 3.3 shows gel images of samples from ganglia from the same horse and samples 
from ganglia from different horses. By carefiil comparison of the gel images from samples 1 
and 2, it was evident that there is also little difference in the protein expression from 
samples taken from the two ganglia from the same horse. Comparison o f sample 2 (and/or 
1) with sample 3 highlights limited variation in the protein content of ganglia from different 
horses.
33 .3  Sex differences in equine autonomic ganglia proteome
The differences in gene expression between males and females are well known on a genetic 
level (Kelly et al, 2002). These differences will, in turn, influence the protein expression. It 
was, therefore, important to establish the differences in protein expression in equine 
autonomic ganglia between the sexes, thus aiding the identification of EGS related proteins 
by eliminating such differences.
Two sections of autonomic ganglia were cut from the control horses with identity 02-182 
(female) and 02-889 (male) and prepared, and the proteins separated by 2D-E. The gels 
were stained with Colloidal Coomassie brilliant blue and scanned using the Amersham 
Pharmacia scanner and Labscan software.
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The gels were analysed by subjective visual comparison and differences were highlighted 
(fig. 3.4). The gels in figure 3.4 show there were only a few differences in the protein 
expression of autonomic ganglia between male and female horses. There are only three or 
four spots, out of several hundred, that appear more intense on the gel with autonomic 
ganglia from a female horse than that from a male horse. This could imply that these are 
more prominent proteins in female horses. None the less, these intensity differences should 
not affect the comparison o f diseased and non-diseased ganglia.
33 .4  Preliminaiy comparative of AGS tissue and control tissue
A preliminary comparative investigation between diseased and non-diseased tissue was 
earned out to give an indication of the protein differences that might be expected and to 
evaluate the effectiveness of 2D-E analysis for comparing diseased and non-diseased 
samples.
Two sections were cut from the acute grass sickness (AGS) diseased ccg 02-913 (samples 1 
and 2) and two sections from the control ccg 01-681 (samples 3 and 4). The samples were 
run through 2D-E to separate the proteins. To visualise the gels, they were stained in 
colloidal Coomassie blue and scanned using the Amersham Pharmacia light scanner and
By subjective visual comparison of the gel images (figure 3.5), it was easy to identify some 
major differences between the diseased and non-diseased tissues. Interestingly, some of the 
same differences occur between both o f the AGS infected samples and their controls, 
implying that they could be diseased related. These gels confirmed the potential of 2D-E 
analysis of diseased and non-diseased samples for identifying EGS-related proteins.
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Figure 3.2. Analysis of protein expression along the length of the ganglia. Six 
sections of one ganglion were taken and homogenised, then the proteins 
separated using 24cm, pH4-7, colloidal coomassie blue stained 2DE gels. 
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Figure 3.2. Analysis o f  protein expression along the length o f  the ganglion.
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Figure 3.3. Analysis of the protein expression in samples from (1) two different 
ganglia from the same horse (a + b) and (2) ganglia from different horses (a/b + 
c) using 24cm, pH4-7 colloidal coomassie blue stained 2D-E gels. 
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Figure 3.4. Analysis of (a) female and (b) male protein expression in 
equine autonomic ganglia on 24cm, pH4-7, Colloidal Coomassie Blue 
stained 2D-E gels. The blue arrows indicate protein spots that appear 
to be expressed relatively more strongly in the female.
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Figure 3.5. Preliminary analysis of protein expression of samples from AGS (a 
and c) infected ganglia with control ganglia (b and d) on 24cm, pH4-7, Colloidal 
Coomassie Blue stained 2D-E gels. Green arrows indicate spots that appear to 
only occur on or are more strongly expressed on control sample gels than AGS 
gels, whilst red arrows indicate spots that appear to only occur on or are more 
strongly expressed on AGS sample gels than control gels. Gel (a) was 
compared with gel (b) and (c) with (d). 
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Figure 3.5. Preliminary analysis of protein expression of samples from AGS (a 
and c) infected ganglia with control ganglia (b and d) on 24cm, pH4-7, Colloidal 
Coomassie Blue stained 2D-E gels. Green arrows indicate spots that appear to 
only occur on or are more strongly expressed on control sample gels than AGS 
gels, whilst red arrows indicate spots that appear to only occur on or are more 
strongly expressed on AGS sample gels than control gels. Gel (a) was 
compared with gel (b) and (c) with (d).
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Figure 3.6. A 24cm, pH4-7, 2D-E gel of control autonomie ganglia showing the 
spots numbered and used in the pick-list for the spot picker robot.
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3.3.5 Evaluating MALDI-MS for the characterisation of equine proteins
The 2D-E gel of control equine autonomic ganglia was used to create a picklist of 
protein spots (figure 3.6). The spots chosen for the picklist were representative of the 
most intense and focused spots on the gel. The picklist was transferred to the Ettan 
Spot Picker Robot, which then automatically picked the spots and performed an in­
gel trypsin digest in preparation for MALDI-MS. The resultant peptides were 
fragmented and mass analysed by the PerSeptive BioSystems Voyager DE-STR 
MALDI-MS, from which peptide mass finger print spectra were obtained. The 
BioSystems Voyager Data Explorer software was used alongside the Mascot data 
search engine to search the NCBI database for protein matches. Table 3.1 shows the 
proteins that were identified with a significant (p< 0.05) hit.
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3.4 Discussion
From the experiments described in this chapter, it can be concluded that any differences in 
the protein expression between sections of equine autonomic ganglia whether taken from 
(1) different locations within the same ganglia, (2) different ganglia from the same horse, 
(3) ganglia from different horses of the same sex or (4) ganglia from horses of different 
sexes, would not interfere with the identification of EGS-related proteins. The differences in 
protein expression, in the latter two cases especially, is perhaps a surprising result given that 
the genetic variation between two horses could be quite substantial especially if they are of 
different breeds (Kelly et al, 2002).
All the gels produced in this chapter showed good consistency regarding the pattern of 
protein expression. Having compared the patterning throughout several sets of gels it was 
concluded that later comparative analyses of EGS-affected autonomic ganglia and control 
autonomic ganglia would be practical.
The preliminary comparative investigation between AGS affected autonomic ganglia and 
control ganglia provided some useful and very interesting results. It appears from this series 
of experiments that there may well be several distinct protein differences between ganglia 
taken from diseased horses and from those from control horses. Further experiments were 
performed (chapter 4) to determine whether these differences were disease related and if 
they occurred in all diseased samples.
Following MALDI-MS of protein spots and the analysis of the resulting peptide mass 
fingerprint spectra by a Mascot database-search of the NCBI database, several proteins were
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characterised. Thirty-four out of sixty equine proteins gave significant hits to various 
proteins such as serum albumin precursor, transferrin, tropomyosin beta chain, vimentin, 
lipocalin and alpha-1-antitrypsin (Table 3.1). A further seven proteins were matched with 
hits that were nearly significant. The matches to semm albumin precursor and transferrin 
are consistent with previous studies of the protein expression of equine autonomic ganglia 
(Griffiths et al, 1994b), which suggest semm proteins are regularly found within ganglia. 
Vimentin is a neural filament protein and is therefore also an unsurprising match (embl 
harvester, see Appendix 2). Tropomyosin is most commonly found in muscle tissue; 
however, it also plays an active role in the transport and assembly of microtubule structures 
(embl harvester, see Appendix 2).
There were a number of proteins that matched proteins fi*om a variety of other species, 
ranging from Homo sapiens to Mus musculus (mouse). These proteins matches are unlikely 
to represent real matches and demonstrate the limitation of using MALDI-MS data to 
identify proteins from an organism for which there is limited genome information. Whilst 
the MALDI-MS analyses in this chapter has enabled a preliminaiy proteome map of equine 
autonomic ganglia to be constmcted, a full proteome map will have to await the more 
complete genome sequence of the horse. The limitations of MALDI-MS analysis when 
using a small genome database can be partially overcome by the use of tandem MS. This 
method of mass spectrometry generates individual peptide fragmentation data rather than 
polypeptide mass fingerprints and hence is more useful for identifying proteins via analysis 
of common peptides conserved between homologous proteins.
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In subsequent chapters both MALDI-MS and tandem MS analyses were therefore used for 
identification of differentially expressed protein samples.
At this stage it is not practical to attempt a complete proteome map of equine tissues. Such 
analyses will have to await the publication of a genome sequence for the horse.
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Chapter Four: Comparison of AGS samples and control 
samples: Identifying EGS related proteins
4.1 Introduction
The main aim of the work carried out in this chapter was to produce 2D-gels of EGS- 
affected ganglia and compare them with gels of control samples. The control ganglia 
came from horses that had died or were euthanased due to causes completely unrelated 
to EGS, e.g. euthanasia due to extreme lameness. Then the gels were analysed and any 
consistent differences in the protein content between gels of AGS and control samples 
were highlighted. Once the protein spots thought to be EGS-related had been isolated 
and picked using the spot picker robot, they were identified using mass spectrometry 
and by searching the NCBI database for protein matches. By identifying these EGS- 
related proteins, it was hoped that clues to the aetiology of the disease might be found.
The proteins were first characterised using MALDI-MS, as described in the previous 
chapter. However, the degree of efficiency of MALDI-MS was limited due to the lack 
of current information regarding the equine genome (Chapter 3). Thus tandem mass 
spectrometry was used in addition to MALDI-MS. Tandem Mass Spectrometry induces 
fijrther fragmentation of peptides and allows mass analysis of the fragmented ions. 
Fragmentation is achieved by inducing ion/molecule collisions by a process known as 
collision-induced dissociation (CID), CID is accomplished by selecting an ion of 
interest with a mass analyser and inducing that ion into a collision cell (Lesney, 2001). 
The selected ion then collides with a collision gas (e.g. argon or helium) resulting in 
fragmentation. The fragments are then analysed to obtain a fragment ion spectrum
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(Lesney, 2001). Tandem mass analysis is mainly used to obtain further information 
about a compounds sequence.
4,1,2 Aims
• To analyse 2D-E gels of EGS-affected autonomic ganglia alongside gels of
control autonomic ganglia.
• To identify and extract any proteins that appear to be EGS-related.
• To characterise any EGS-related proteins by mass spectrometry and investigate
their possible fijnctional association with EGS.
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4.2 Materials and methods
4.2.1 2D-E gel comparison of diseased and non-diseased samples
2D-E gels were run, as previously described, of equine autonomic ganglia to compare 
EGS-affected samples with control samples (Table 4.1). Spots that appeared most 
consistently up- or down-regulated were highlighted. A picklist for the Ettan Spotpicker 
Robot (Amersham Pharmacia Biotech) was created using the hnageMaster® 2DElite 
software (Amersham Pharmacia Biotech).
Table 4.1 Summary of 2D-E gel-to-gel comparisons relating to each set of gels run.
Group Comparisons EGS Case Number Control Case Number
1
03-345
02-88903-359
03-425
2 02-248 01-9133
02-913
3 02-352 02-56
02-376
4 02-302 02-182
02-349
5
03-392
02-889
03-409
03-408
03-425
03-445
4.2.2 Identification of proteins
Fourteen spots fi’om the gel containing sample from the AGS autonomic ganglia 03-425, 
chosen for its optimal spot focusing and intensity, (Fig 4.2), were picked and in-gel 
trypsin-digested using the Ettan Spotpicker Robot (Amersham Pharmacia Biotech). The 
spots were presented to the PerSeptive BioSystems Voyager DE-STR MALDI-MS. The 
obtained peptide mass fingerprint spectra were subsequently compared to spectra already 
in the protein database (NCBI) using the BioSystems Voyager Data Explorer and Mascot 
software packages to search for protein matches. The peptide samples of the spots, also 
obtained from the Spotpicker Robot, were run through the BioSystems Q-STAR tandem 
MS and the spectra were analysed using the Analyst QS software/Bio Analyst software. 
Protein matches were searched for using the Mascot database search engine.
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4.3. Results
4.3.1 Comparison of AGS sample gels and control sample gels: determination of AGS 
related proteins.
The first step in comparing diseased and non-diseased (control) samples was to separate the 
proteins of all diseased samples on 2D-E gels alongside control samples in order to isolate the 
protein spots that were most consistently different between diseased and non-diseased ganglia 
samples. Both chronic grass sickness (CGS) and acute grass sickness (AGS) samples were 
subjectively analysed and visually compared with controls.
A total of 15 gels were run with sample fiom EGS affected autonomic ganglia (13 AGS and 2 
CGS), as 5 sets of comparative gels. In each set one section of control autonomic ganglia was 
taken along with several different sections of EGS affected ganglia. Each set of comparative 
samples was separated using 2D-E using the methods developed in Chapter Two. The gels 
were then stained in Colloidal Coomassie brilliant blue and scanned using the Amersham 
Pharmacia light scanner and Labscan software.
Once EGS and control autonomic ganglia gels had been run, each set of gels was compared 
(Fig 4.1 and Appendix 1; however, it should be noted the gel images included in the text are of 
poorer resolution to the screen based high-resolution images used during analysis, leaving gel 
comparisons from figures in the thesis open to error). Throughout the sets there were six 
consistent absences of protein spots on the majority of control gels compared to the gels run 
with AGS-affected ganglia. These spots were highlighted throughout the series of sets of 
comparative gels with arrows (Fig 4.1 and Appendix 1). A further eight spots, also highlighted 
with arrows, appeared on both EGS gels and control gels but showed consistent up-regulation 
of their expression on the majority of EGS gels (with the exception of spot 10 on gel (c) 
Appendix 1, Fig B and spot 13, on gel (a) Fig 4.1 were they are of similar relative intensity to 
those on comparative gels). Highlighted spots may be relevant to the determination of the 
disease pathway and were analysed (Fig. 4.2). The two gels of CGS-affected sample showed 
similar protein expression to those run with AGS sample. Some of the differential proteins on 
AGS sample gels were more intense on the CGS sample gels.
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Figure 4.1. Four 24cm, pH4-7, Colloidal Coomassie blue stained 2D-E gels, analysing 
CGS, AGS and control autonomic ganglia for differences in protein expression. The red 
arrows indicate spots that, after a visual analysis of all comparative gels run, most 
consistently only appear on EGS gels or that most consistently show up -regulation in 
response to EGS. They also relate to those numbered in Fig 4.2.
(a) control 02-889
* f
(b) CGS 03-345
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Figure 4.1 2D-E gels analysing CGS, AGS and control autonomic ganglia
r
♦ f
(b) CGS 03-359
/■
(d) AGS 03-425
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Figure 4.2. A 24cm, pH4-7, Colloidal Coomassie Blue stained 2D-E gel of AGS 
autonomie ganglia, showing the protein spots that were most consistently up-regulated 
or most consistently only appearing on EGS gels, after the subjective analysis of all 
comparative sets of gels run. These spots represent the picklist to be excised by the 
spot-picker robot and for the MS analysis of proteins thought to be EGS-related.
s I
4.3.2 Identification of proteins by MALDI-MS
The 2D-E gel labelled AGS 03-425 (Fig 4.2) was analysed using the ImageMaster 2D 
Elite Software and a protein picklist was generated. The fourteen proteins that were 
differentially expressed in EGS tissue were selected from the gel. The protein picklist 
was then transferred to the Ettan Spot Picker Robot, which then automatically picked 
the relevant protein spots, in accordance with the picklist. Self-adhesive markers had 
been attached to the gel backing prior to scanning to create a link between the electronic 
image and the actual gel. The Ettan Digester, working alongside the spot picker, 
automatically tracked samples from spot picking and performed in-gel digestion of 
proteins, using trypsin and yielded peptide fragments, which were transferred onto a 
target plate ready for MALDI-ToF analysis.
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The target plate, obtained from the spot picker robot, containing the protein spots was 
inserted into the Biosystems Voyager MALDI-ToF mass spectrometer. Using the 
computer software, each spot was highlighted, ionised, fired at and then mass analysed. 
The protein fragmentation patterns were then compared with the patterns predicted for 
all proteins within a database (e.g. NCBI) and matches were statistically evaluated. 
Since the presence of Arg and Lys residues are common, trypsin cleavage (specific for 
Arg and Lys) usually produces a large number of fragments, which in turn offer a high 
probability of identifying the target protein. However, the success of protein 
identification by this method relies on the existence of the protein sequence within the 
database. The following proteins were identified corresponding to the proteins in the 
picklist as on the gel in Figure 4.2 (Table 4.2):
Table 4.2. Protein identities of spots from a 2D-E gel run (fig 4.1) with AGS 
autonomic ganglia sample after MALDI-MS.
spot
no. protein
Genlnfo
Identifier species
score
(*)
peptides
mathched*
mass
(Da)
Protein that aoDcarcd onlv on AGS gels
3 hypotlietical protein gi 23021297
Clostridium
thermocellum 43(63) 4 28623
4 tliiamine phosphate gi 18310318
Clostridium
perfringens 44(63) 4 23018
5
alpha-1 -antitrypsin/
p-21
gi 3982489 
gi 619266
Equus caballus/ 
Clostridium botul...
59(57)
60(63)
7
5
47141
19571
7 fibroblast growtli factor gi 1807390 Equus caballus 43(57) 4 15223
10 serum albumin precursor gi 543794 Equus caballus 86(74) 12 70550
16 beta tubulin gi 135490 Sus scrofa 60(57) 5 50285
Un-resnlated proteins
6 gamma enolase g i 182118 Homo sapiens 111(74) 15 44568
8 serum albumin precursor gi 543794 Equus caballus 49(57) 11 70550
9 transferrin gi 6176213 Equus caballus 39(57) 3 7052
11 fibroblast growtli factor gi 1807390 Equus caballus 59(57) 6 15223
12 Phosphoribosyl 
pyrophosphate synthetase gi 18310531
Clostridium
perfringens 62(63) 8 41888
13 heat shock protein 60 g i 1334284 Rattus norvégiens 131(74) 21 58061
14 serum albumin precursor gi 543794 Equus caballus 85(74) 23 70550
15 serum albumin precursor gi 543794 Equus caballus 71(57) 15 70550
* Score required for a match of significance p<0.05 
 ^a recommended minimum of 4 peptides should be matched
For those spots that remained unidentified or needed verification of their identification 
after MALDI-MS analysis, their digested peptides were then analysed using the 
BioSystems Q-Star tandem MS to obtain further information regarding their structure.
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4.3.3 Identification of proteins by tandem MS
Because of the limited applicability of MALDI-MS analysis for species with limited 
genome information, tandem mass spectrometry (MS/MS) was employed to reveal the 
necessary structural information and aid the characterisation of the proteins. The 
BioSystems Q-Star MS system was used along with Analyst QS software/Bio Analyst 
software to run the extra sequence information generated through the Mascot database 
search engine to search for protein matches. Table 4.3 displays the resulting 
characterisations:
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Table 4.3. Protein identities of spots from a 2D-E gel run with AGS autonomic
spot
no.
protein Genlnfo
Identifier
species score
Ô
peptides
matched
mass
(Da)
Proteins that onlv annear on AGS eels
3 serum albumin precursor gi 543794 Equus caballus 219 6 68554
4 serum albumin precursor gi 543794 Equus caballus 199 5 68554
5 *alpha-l-antitrypsin gi 3982489 Equus caballus 97 3 46913
7 gamma enolase gi 182118 Homo sapiens 172 4 44168
10 serum albumin precursor gi 543794 Equus caballus 301 11 68554
beta casein precursor gil3661026 Bos taurus 90 2 25091
16 *beta-tubulin g i 109432 Chinese hamster 524 13 49716
osetoglobin precursor gi 129077 Bos taurus 184 5 34188
HSP60 gi 129378 Cricetulus griiseus 110 2 60950
beta casein precursor gi 115660 Bos taurus 77 1 25091
Un-recnlated nrotcins
6 ♦gamma enolase g i 182118 Homo sapiens 876 44 44168
phosphopyruvate hydratase gi 1363309 Rattus norvégiens 703 16 47096
beta-tubulin gil6088719 Homo sapiens 169 5 49640
peripherin gi 91171 Mus musculus 93 4 50679
8 ♦serum albumin precursor gi 543794 Equus caballus 229 10 68554
9 serum albumin precursor gi 543794 Equus caballus 57 1 68554
11 haptoglobin-1 precursor gi 123507 Homo sapiens 168 5 38427
beta casein precursor g i 115660 Bos taurus 72 2 25091
beta actin gi 28336 Homo sapiens 69 2 41786
serum albumin precursor gi 543794 Equus caballus 60 2 68554
12 haptoglobin-1 precursor g i 2118092 chimpanzee 106 3 38843
peripherin gi 730299 Homo sapiens 97 3 53846
beta casein precursor g i 115660 Bos taurus 87 2 25091
13 chaperonin groEL precursor g i 72957 Mus musculus 1372 42 60903
♦chaperonin (HSP60) gi 306890 Homo sapiens 1294 41 60986
peripherin gi 730299 Homo sapiens 355 7 53846
phosphoprotein gi 473912 Mus cookii 251 6 50961
♦intemexin neural intermediate
filament protein gil4249342 Homo sapiens 105 6 55357
beta casein g i 115660 Bos taurus 79 2 25091
beta-tubulin gi 92930 Rattus norvégiens 74 1 49905
14 ♦serum albumin precursor gi 543794 Equus caballus 666 18 68554
chaperonin(HSP60) gi 306890 Homo sapiens 308 7 60986
albumin gil9705431 Rattus norvégiens 166 5 68674
ssDNA-binding protein gi 346338 Homo sapiens 99 3 34648
15 ♦serum albumin precursor gi 543794 Equus caballus 625 12 68554
kappa casein precursor gi 162811 Bos taurus 55 1 21212
* denotes hits that had also been identified with MALDI-MS
 ^the score required for a hit of significance p<0.05 is 67
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Figure 4.3. 2D-E gel of AGS affected ganglia showing the final identities of 
proteins thought to be AGS related.
5. a-l-antitr>'psin 
4. serum albumin 
precursor
6.gamma enolase
11. haploglobin-1- 
precursor
12. haptoglobin-1- 
precursor
8.serum albumin 
precursor
3. serum albumin 
precursor
13.heal shock 
protein
14.serum albumin 
precursor
15.serum albumin 
precursor
10.serum albumin 
precursor
16. beta tubulin
7. gamma enolase
9. serum albumin 
precursor
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4.4. Discussion
Following MALDI-MS analysis of spots thought to be EGS-related proteins, several 
spots were significantly matched to proteins from the NCBI database. Gamma enolase, 
a glycolytic enzyme that is found in nervous tissue, was identified at spot 6 with a score 
of 108 (74 was needed for a match of significance of p < 0.05). Therefore, this was a 
likely match. Tandem MS, confimied spot 6 as gamma enolase with a highly significant 
score of 876. The identification of fibroblast growth factor (FGF) at spot 11 (score 59; 
57 needed for significance) and tentatively at spot 7 (score 43; 57 needed for 
significance) are also likely matches. However, following tandem MS spot 7 was 
characterised as gamma enolase (with a score of 172). In addition, spot 11 was 
characterised as haptoglobin-1 precursor (with a score of 168) using tandem-MS and not 
fibroblast growth factor as suggested by MALDI-MS. The strength of the score for 
haptoglobin-1 precursor, combined with serum proteins having been isolated from 
autonomic ganglia before (Griffiths et al, 1994) suggests this is the most likely match.
Beta tubulin was identified at spot 16, being matched with proteins from Bos taurus 
(MALDI-MS) and Chinese hamster (tandem-MS), significant hits were achieved on 
both accounts (60 requiring 57, and 524 needing 67 respectively). Beta tubulin is 
observed in cells of most tissues and plays a significant role in the assembly of the 
microtubule support stmctures found in cells, including neuronal cells. Although beta- 
tubulin has not yet been sequenced for Equus caballus, it was identified by tandem MS 
probably because of the highly conserved nature of the beta-tubulin gene.
Serum albumin precursor was consistently identified at several spots on EGS gels. It 
was characterised at spots 8, 10, 14, and 15 after MALDI-MS, these being confirmed 
following tandem MS. Tandem MS also gave rise to additional characterisations of 
serum albumin precursor at spots 3, 4 and tentatively at 9. Serum albumin precursor is
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usually found in blood. However, its presence within the ganglia is consistent with 
previous findings that autonomic ganglia contain serum proteins including albumin 
(Griffiths et al, 1994). Alternatively it could result from inadvertent contamination of 
the ganglion with blood or serum during the post mortem collection of the ganglia. 
However, this is unlikely given that the contamination would not have penetrated 
through the ganglion capsule into the central part of the tissue that was used for the 
analysis. In addition, it would be expected that its presence would be consistent in both 
EGS and control gels. It is also possible that the protein could be found within the 
extracellular space, or in the small capillaries supplying the neuronal tissues.
MALDI-MS identified transferrin, as the main, albeit not significant, candidate at spot 
9. Transferrin is an iron binding transport protein responsible for the transport of iron 
from sites of absorption and haeme degradation to those of storage and utilisation. 
Serum transferrin may also stimulate cell proliferation (embl harvester, see Appendix 
2). Again it is possible, although unlikely, that the contamination of the ganglia, during 
post mortem, could have resulted in transferrin being found within the tissue. 
Alternatively, transferrin may have been present in the tissue to minimise iron mediated 
cell damage. It also is possible that spot 9 might contain a mixture of both proteins. 
Transferrin may have been bound to serum albumin and co-migrated on the 2D-E gel.
Several Clostridial proteins were also tentatively recognised in the AGS affected 
autonomic ganglia by MALDI-MS. A ‘hypothetical protein’ from Clostridium 
thermocellum was the most significant match at spot 3, a thiamine-phosphate protein 
from Clostridia perfringens at spot 4 and phosphoribosyl also from Clostridium 
perfringens at spot 12, These were particularly interesting finds given the suspected role 
0 Î Clostridium botulinum in EGS (Hunter et al, 1999). The proteins may not have been 
significant hits for the botulinum proteins, but given that C. botulinum has not been
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fully sequenced yet, it could be possible that these proteins do derive from C. 
botulinum. If this were the case, it might help implicate the role of C. botulinum in EGS. 
However, highly significant hits for serum albumin precursor (at spots 3, 4, and 5) and 
haptoglobin-1 precursor (at spot 12) were found when these spots were subsequently 
analysed by tandem MS.
Furthermore, after MALDI-MS, there were conflicting results with a relatively high 
score at spot 5, but no significant match, for either alpha-1-antitrypsin {Equus caballus) 
or for p21 from C. botulinum. However, it was again the case that tandem MS produced 
a significant hit -  for alpha-1-antitrypsin. It could be that these spots (3,4 and 5), at 
which Clostridial proteins were recognised, but no significant hit was made, are the 
proteins that tandem MS matched but that they had Clostridial proteins associated with 
them. For instance, the Clostridial proteins may be bound to serum proteins as carrier 
molecules.
The chaperonin groEL precursor, characterised at spot 13 by both MALDI-MS and 
tandem MS, is a heat shock protein. Heat shock proteins are involved with protein 
folding and transport across membranes. They prevent misfolding and promote the 
refolding and proper assembly of unfolded polypeptides generated under stress 
conditions, such as during disease, within the mitochondrial matrix (Edenhofer et al, 
1996). Therefore, an up-regulation of a chaperonin protein could be a likely observation 
during EGS.
In conclusion, the strength of the hits that were generated after tandem MS implies that 
they are the most likely characterisations for the proteins highlighted as being EGS- 
related. However, the characterisation results obtained after MALDI-MS should not be 
discarded as they potentially present some interesting leads for further investigation.
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However this analysis further underlies the difficulties of protein identification by mass 
spectrometry in an organism that has limited genome sequence data. This is underlined 
by the fact that a few of the top matches for equine proteins hit proteins from another 
species such as rat and human. Whilst these may reveal some interesting homologies, 
of these hits may also prove suspicious or require a more detailed investigation.some
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Chapter 5: Final discussion and conclusions
For the past century equine gi'ass sickness has puzzled scientists, vets and horse owners 
alike. Pievious attempts to understand EGS have found autonomic dysfunction, 
especially within the gastiointestinal tract, with neuronal damage and loss in affected 
areas. The cunent hypotheses suggest EGS is a toxicoinfection with Clostridium 
botulinum type C (Hunter et al, 1999; Hunter and Poxton, 2001). Most horses have been 
exposed to the bacterium and the normal gut flora can usually resist growth of the 
organism and any pioduction of its toxins (Poxton, Equine Grass Sickness Fund website). 
There are two hypotheses for a putative trigger for the overgrowth of C. botulinum'.
1. Oxidative stress and excitotoxicity of plants during periods of rapid growth or 
extreme weather conditions (McGorum et al 1998; 2000).
2. Cyanide fi'om wild white clover (Doxey, 1991).
The aim of this project was to compare protein expression, using proteomic techniques, 
of homogenates of cranial ceiwical ganglia collected from horses that had AGS and those 
of control horses. An optimal and reproducible method for the 2D-E analysis of 
autonomic ganglia was developed (Chapter 2) to allow the production of good quality 
gels with the optimal separation of proteins for the comparative investigations of equine 
autonomic ganglia that were to follow. A series of comparisons were then run to 
deteimine the extent of protein variation between homogenates of ganglia from the same 
ganglia, the same horse, different horses and horses of different sexes. These experiments 
were aimed at making the final comparisons of EGS and control samples easier by
eliminating protein differences that were unrelated to EGS, which may occur between 
samples. The effectiveness of MALDI-MS was also evaluated at this point with respect to 
characterising equine proteins. Approximately sixty spots from a control (using non­
diseased autonomic ganglia) gel were excised, digested and run through MALDI-MS. 
The acquired mass finger-print spectra were used to identify as many of the proteins as 
possible by comparing them to those already stored within the NCBI database. Thirty- 
five spots were characterised at this point, with a significant score indicating they were 
not random matches. A further eight spots were matched to proteins in the database, but 
with a score just below the required score to gain a significant score and so there is a 
chance these hits could be random events. However, given that approximately 30% (17 
spots) were not characterised, further information on the acquired peptide 
sequences/structures would be required to characterise all spots from equine autonomic 
ganglia. None-the-less, the start of a preliminary proteome map was compiled for equine 
autonomic ganglia (Chapter 3). This will provide a good reference, and starting point, for 
others investigating EGS.
2D-E gels were then run to compare the AGS affected autonomic ganglia samples with 
like samples from control horses (horses that had died or were euthanased due to 
circumstances unrelated to EGS). The gels were studied and the protein spots that most 
consistently occurred either only on gels of AGS sample or only on gels of control 
samples, or were most consistently up or down regulated were highlighted. A typical 
AGS gel was taken and 14 spots, considered to be EGS related, were digested and 
excised using the spot picker robot and analysed using MALDI-MS. The spectra obtained
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from MALDI-MS were compared against spectra already in the NCBI database using the 
Mascot database search engine software. Seven of the proteins were significantly 
identified at this point. Although some of these proteins occur in neurones under normal 
ciicumstances, it is the case that some have been shown to be up regulated during 
neuronal damage or ischaemia. For example, gamma enolase, which was found to be up 
regulated at spot number 6, is a neurone specific, glycolytic enzyme that catalyses the 
inter-conversion of 2-phosphoglycerate to phosphoenolpyruvate in the glycolytic 
pathway (Takei et al, 1991). Gamma enolase exists in three molecular forms in the 
human brain: non-neural enolase, neurone-specific enolase and the unstable alpha, 
gamma- enolase. Interestingly, the neurone specific form is a highly acidic protein of 
78kDa, which has been found not only in central and peripheral neiwous elements but 
also in derivative tumours. Cell injury causes the release of the enzyme into the blood and 
cerebrospinal fluid (CSF). In fact, the measurement of neurone-specific enolase levels in 
serum and CSF following cerebral ischaemia and traumatic head injuries provides a 
reliable indicator of the degiee of brain cell damage (Takei et al. 1991). It could, 
therefore, be possible that the up regulation/ appearance of gamma enolase seen in AGS 
affected equine autonomic ganglia could be a direct result of the neuronal damage caused 
by the disease.
In addition, at spots 7 and 11, fibroblast growth factor (FGF) was initially identified using 
data obtained fiom MALDI-MS. FGF, a member of the heparin iron-binding family, is 
found in neuiones and has several roles, but is most commonly involved in nervous 
system development and function (embl harvester, see Appendix 2). Consistent with their
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names it is widely known that most FGFs initiate fibroblast proliferation. However, the 
general FGF designation is obviously limiting by its description of one target cell and one 
biological activity. For example, the FGF-2 molecule has been shown to be more than a 
growth factor. It induces adipocyte differentiation, stimulates astrocyte migration and 
prolongs neuronal survival (Strutz et al, 2002). Again, it could be plausible that the up 
regulation/appearance of FGF is a consequence of EGS causing neuronal damage.
Furthermore, the up regulation/appearance of beta tubulin at spot 16, could also be a 
response to EGS. Axonal injury of adult neurones results in several changes that are 
detectable in the cell body, including changes in the levels of many types of mRNAs. In 
the peripheral nervous system, an overall increase in the total tubulin mRNA is observed 
after peripheral neiwe injury (Fournier et al, 1997). This pattern of beta tubulin 
expression is seen in neurones undergoing a neurogenic response to either physical or 
chemical lesions in the adult neuroepithelium (Roskams et al, 1998). Under normal 
circumstances the tubulin proteins assist microtubule assembly during embryonic 
development. However, it is also considered that beta-III tubulin plays an important role 
in axonal gi'owth because of its unique neurone-specific pattern of expression and its 
substantial increase in neurones that have been stimulated to regrow their axons, 
following axotomy for example (Moskowitz et al, 1993). A similar increase in beta-III 
tubulin may well result following neuronal damage, such as that occurring during the 
course of EGS.
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Another protein that is of potential interest is alpha-1-antitrypsin, which was 
characterised at spot 5. Alpha-1-antitrypsin is an inhibitor of serine proteases (embl 
haiwester, see appendix 2). It primarily protects elastin fibres and other connective tissue 
components from degradation by neutrophil elastase (Song et al, 1998). Alpha-1- 
antitrypsin is a major plasma protein (Tardiff and Krauter, 1998) which has been isolated 
fi'om equine plasma (Laegreid et al, 1982), which has a role in tissue repair by 
stimulating fibroblast proliferation and procollagen production (Dickenson and Alpher 
1994). It could play such a role in neural tissue, since a disturbed balance between the 
proteolytic activity and protease inhibition in the pericellular environment has been 
implicated to contribute to the development of pathological changes during 
neurodegenerative disease, such as Alzheimer’s disease (Meins et al, 2001). Thus, it 
could well be the case that the causative agent of EGS may well tiigger a cascade of 
events that results in a disruption in the balance between proteolytic activity and protease 
inhibition, such as that provided by alpha-1-antitrypsin. The end result would be the 
neurodegeneration seen in EGS cases. Moreover, alpha-1-antitrypsin is an acute phase 
protein which is up-regulated in response to cell injury. Milne and colleagues (1994) have 
shown similar acute phase proteins have been identified in the blood of horses with AGS.
The protein spots that remained unidentified, but were thought possibly to contain small 
amounts of protein derived from Clostridia, were particularly interesting given the 
suspected role of Clostridium botulinum in EGS (Hunter et al, 1999). The proteins may 
not have been significant hits for Clostridia botulinum proteins, but given that C. 
botulinum has not been fully sequenced yet; it could be possible that these proteins do
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derive from C. botulinum. This requires further investigation, for example, by picking 
and running the coiTesponding spots fiom other AGS affected sample gels through MS to 
see if  further hits for Clostridial proteins occur. If Clostridial proteins appeared in all 
coiTesponding spots on all gels, it would help support the role o f C. botulinum in EGS.
The peptides of the protein spots were run through tandem MS in an attempt to 
characterise the remaining proteins and confirm the identity of those already 
characterised by MALDI-MS. The exti’a structural infonnation provided by tandem MS 
resulted in all spots being characterised, with the majority having highly significant 
matches. Spot 5 was conflnned as being alpha-1-antitrypsin, spot 6 as gamma enolase, 
spot 8, 14 an 15 as serum albumin precursor, spot 13 as a chaperonin protein/lieat shock 
protein and spot 16 as beta tubulin. These confinnations of protein characterisation help 
validate the efficiency of MALDI-MS with respect to identifying equine proteins, as 
evaluated in Chapter 3, but only if the coiTesponding gene sequences are available.
Those proteins that were not significantly matched following MALDI-MS were 
characterised following tandem MS. For example, spots 3, 4, 5 and 12 that were 
originally tentatively matched to Clostridial proteins were characterised as serum 
albumin precursor (spots 3 and 4), alpha-1 -antitiypsin (5) and haptoglobin-1-precursor 
(12) by tandem MS. In some respects this was somewhat disappointing because a positive 
match to Clostridial proteins would have supported the link between Clostridium 
botulinum and EGS (Hunter et al, 1999). Spot 7, tentatively matched to fibroblast growth 
factor using MALDI-MS data, was then strongly matched to gamma enolase, whilst spots
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9 and 11 (with tentative matches to transferrin and fibroblast growth factor respectively) 
were then significantly characterised as serum albumin precursor and haptoglobin-1 
precursor respectively. By comparing the results of the two formats of MS, it can be 
concluded that when working with a species with a limited genome project and hence 
little information concerning characterised proteins, tandem MS is an extremely valuable 
tool.
The matches to haptoglobin at spots 11 and 12 following tandem MS were also 
interesting. Haptoglobin-Ts usual role is to combine with free plasma haemoglobin to 
prevent the loss of iron through the kidneys and hence, protect the kidneys from damage 
by haemoglobin, while at the same time making haemoglobin accessible to degenerative 
enzymes. The beta chain is related to serine proteases, but displays no enzymatic activity 
itself (embl haiwester, see Appendix 2). The function of haptoglobin-1 precursor in the 
equine autonomic ganglia is unclear, and there has been no published data of it having 
been characterised in neural tissue before. Why it was up-regulated during EGS is also 
unclear.
Serum albumin precursor was characterised at spots 8, 10, 14, and 15 after MALDI-MS 
and this was confirmed following tandem MS. Tandem MS also showed serum albumin 
precursor at spots 3, 4 and tentatively at 9 as well. Serum albumin precursor is usually 
found in blood, but there are previous findings that autonomic ganglia from EGS horses 
contain serum proteins including albumin (Griffiths et al, 1994).
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A heat shock protein, Chaperonin groEL precursor, was characterised at spot 13 by both 
MALDI-MS and tandem MS. Heat shock proteins are involved in the folding and 
mitochondrial tiansport of proteins across membranes (embl harvester, see Appendix 2). 
They are also reported to help prevent misfolding and promote the refolding and correct 
assembly of unfolded polypeptides generated under stress conditions, such as during 
disease, within the mitochondrial matrix (Edenhofer et al, 1996). Hence, an up-regulation 
of a chaperonin protein is a likely obseiwation during EGS.
There were also several spots that displayed high scores for several proteins. For 
example, spot 13 had scores in 4 figures for heat shock proteins, but also a score of 355 
for peripherin (an adhesion molecule found in peripheral neiwous tissue membrane (embl 
haiwester, see Appendix 2)), a score of 251 for phosphoprotein (inhibits apoptosis and 
regulates glucose transport in most tissue types (embl harvester, see Appendix 2)) and a 
score of 105 for a neural intermediate filament protein. All of these hits are very 
significant and plausible matches, however, the huge scores obtained for heat shock 
proteins imply that this spot was most likely to be a heat shock protein. It is possible, 
however, that there could be a mixture of proteins at this position on the gel. Similar 
situations also occurred at spots 11,14 and 16.
The repeated appearance of casein precursors, a milk protein, was a suiprising result. It 
was significantly matched at spots 10, 11, 12, 13, 15 and 16. This was obviously an 
unexpected hit and unexplainable. There is no obvious reason why a protein that, 
according to literature, occurs exclusively in milk and mammary glands (embl harvester,
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see Appendix 2) would occur in autonomic ganglia. It could be that casein has been 
characterised and studied so much it has numerous mentions within the database and 
more or less any sequence could match a section of it to a certain degree.
Studying the effect of a disease has its limitations. It confirms the result of the disease; 
the damage caused to tissues, but may not reveal the cause of the disease. However, in 
this project, having studied the damage and the changes occuning to the protein 
expression of autonomic ganglia of horses affected with EGS, it may be possible to 
determine the route of damage. For instance, by comparing the EGS-related proteins 
discovered in this project, with proteins that occurred in other diseases and causes of 
neuronal damage, clues to the route of damage occumng in EGS may be revealed. This 
in turn could help determine what actually caused the damage, i.e. what caused EGS.
The small sample numbers caused further limiting problems in this project, for instance 
with respect to the identified differential expression between diseased and healthy tissue 
warrants further investigation and ideally increased sample sizes. Moreover, animals 
could not be genetically matched in the same way that model organisms can be in 
laboratory experiments, meaning that there are many more variables than tissues just 
being ‘diseased’ or ‘controls’. However, there is no way of avoiding this within the 
circumstances of grass sickness in horses. Horses are too big, and expensive to keep and 
have far too long a gestation period to breed for experimental purposes. In this study, as 
many replicate experiments as possible were run (Chapter 3) to overcome this problem. 
Repeating the experiments carried out in chapter 3 with further samples would confinn
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the consistency of protein expression changes that were highlighted in this project, with 
respect to breed/sex etc.
A further area of this project that could be investigated more fully would be a study of the 
proteins out with the pH range 4-7. Due to time and expenses limitations, gels were not 
optimised for the pH ranges either side of 4-7. However, it may be worth while to 
consider this as there could be further differences between diseased and non-diseased 
samples that could have been picked up within this particular project.
The limited genome project for Equus caballus was another factor that limited the 
proteomic analysis in this project. Having a limited gene bank meant that it was difficult 
to characterise equine proteins. MALDI-MS was especially limited by this factor. As the 
equine genome project continues and more information becomes stored in the databases, 
projects continuing this work will be more useful and conclusive.
However, the work earned out in this project will be of a great help to those continuing 
and embarking upon EGS research. A preliminary proteome map for an equine 
autonomic ganglion has been characterised which will provide a significant reference 
point. Several proteins that most consistently appeared during EGS or were up regulated 
during EGS were characterised. A further investigation into these proteins functions and 
roles both within autonomic ganglia and during disease may help to reveal some clues 
regarding the aetiology of EGS. The possible presence of Clostridial proteins, in the 
autonomic ganglia is especially interesting and deseiwes further investigation.
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Appendix 1
24cm, pH 4-7, Colloidal Coomassie Blue stained 2D E gels
comparing the protein expression of AGS affected equine
autonomic ganglia with control equine autonomic ganglia
Figure A. 2D-E gels comparing the protein expression of EGS affected equine 
autonomic ganglia 02-913 and 02-248 with control equine autonomic ganglia 01- 
681. The arrows indicate spots that either consistently only appear in EGS gels or 
are consistently up-regulated in EGS gels, and correspond to the spots 
numbered for 'picking' in Fig 4.2. 
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Figure B. 2D-E gels comparing the protein expression of EGS affected equine 
autonomic ganglia 02-376 and 02-352 with control equine autonomic ganglia 
02-56. The arrows indicate spots that either consistently only appear in EGS 
gels or are consistently up-regulated in EGS gels, and correspond to the spots
numbered for ‘picking’ in Fig 4.2. 
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Figure C. 2D-E gels comparing the protein expression of EGS affected equine 
autonomic ganglia 02-302 and 02-349 with control equine autonomic ganglia
02-182. The arrows indicate spots that either consistently only appear in EGS 
gels or are consistently up-regulated in EGS gels, and correspond to the spots
numbered for ‘picking’ in Fig 4.2.
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Figure D. 2D-E gels comparing the protein expression of EGS affected equine 
autonomic ganglia 03-3392, 03-409, 03-408, 03-425 and 03-445 with control 
equine autonomic ganglia 02-889. The arrows indicate spots that either 
consistently only appear in EGS gels or are consistently up-regulated in EGS 
gels, and correspond to the spots numbered for ‘picking’ in Fig 4.2.
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Appendix 3
List of Samples (supplied by the Edinburgh Royal (Dick) School of Veterinaiy Studies)
Case/ID No. Date of collection Diagnosis Sex Breed Age
97-1053 15/11/02 control
01-681 07/02/03 control MN
02-889 14/11/02 control MN
02-56 08/05/02 control
02-182 control F
02-642 14/08/02 control F
02-913 17/11/02 AGS F
02-349 12/05/02 AGS MN
02-176 control MN
01-537 control MN
02-248 AGS F
02-376 AGS . MN
02-352 AGS MN
02-302 AGS MN
03-094 24/02/03 control MN TB 5
03-342 05/05/03 AGS F TBx 1 0
03-392 22/05/03 AGS MN TBx 5
03-345 06/05/03 CGS MN Cob 9
03-359 27/05/03 CGS MN Irish cob 7
03-409 27/05/03 AGS MN pony 3
03-408 28/05/03 AGS F TB 8
03-425 30/05/03 AGS MN TBx 5
03-445 03/06/03 SAGS F Highland 3
m
Appendix 4
Commonly used reagents
Lysis buffer
19.2g 8 M Urea,
L 6 g 4% (w/v) CHAPS,
0.194g 40mM Tris Base 
H2 O to 40ml
SDS sample buffer
62.5mM TRIS-HCl pH6 . 8  
1 0 % (v/v) glycerol 
2% (w/v) SDS 
5% (v/v) p-mercaptoethanol
Coomassie Brilliant Blue
0.25g of Coomassie Brilliant Blue R 
90ml of methanol: H2 O (1:1 v/v)
1 0 ml acetic acid
Colloidal Coomassie Brilliant Blue
5% Coomassie stock (5 g Coomassie Brilliant Blue G in 250ml HPLC grade H2O) 
Colloidal stock: 50g ammonium sulphate 
500ml H2 O 
6 ml phosphoric acid 
10ml Coomassie stock
The actual stain: 1 part methanol 
4 parts colloidal stock
TRIS-glycine electrophoresis buffer
15.Ig og TRIS-base 
94g of glycine 
900ml H2 O
50ml of a 10% (w/v) stock solution of electrophoresis-grade SDS 
Adjust the volume, with H2 O, to 1000ml
15% Resolving Gel
4.6ml H2O
10ml 30%acrylamide 
5ml 1.5M TRIS buffer pH8.8 
200pl 10% SDS 
200)il 10% APS 
lOpI TEMED
5% Stacking Gel
3.4ml H2 O
830pl 30%acrylamide 
630pl 1.5M TRIS buffer pH8.8 
50pl 10% SDS 
50pl 10% APS 
5 pi TEMED
Rehydration buffer (stock solution)
12gUrea 
0.5g CHAPS 
trace bromophenol blue 
make up to 25ml H2 O
SDS equilibration buffer
6.7ml 1.5M TRIS-Cl pH8.8 
72.07gurea
69ml glycerol (87% v/v)
4g SDS
a few grains of bromophenol blue 
make up to 200ml H2O
10% APS
lOOmg APS in 1ml H2O
10% SDS
5g SDS 
50ml H2 O
